{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,16]],"date-time":"2026-10-16T12:50:49Z","timestamp":1792155049187,"version":"4.4.0"},"reference-count":273,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,7,24]],"date-time":"2025-07-24T00:00:00Z","timestamp":1753315200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2025,7,24]],"date-time":"2025-07-24T00:00:00Z","timestamp":1753315200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82274566"],"award-info":[{"award-number":["82274566"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Transl Med"],"DOI":"10.1186\/s12967-025-06840-5","type":"journal-article","created":{"date-parts":[[2025,7,24]],"date-time":"2025-07-24T14:18:54Z","timestamp":1753366734000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":3,"title":["Unlocking the mitochondrial functional code: unraveling the pathogenesis of ovarian cancer and innovative targets to inhibit malignant behavior"],"prefix":"10.1186","volume":"23","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-5428-4684","authenticated-orcid":false,"given":"Chen-Yu","family":"Li","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dan-Ni","family":"Ding","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ying","family":"Guo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yang","family":"Fu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ying","family":"Shen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jiang-Mei","family":"Fu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cheng-Xin","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5953-3608","authenticated-orcid":false,"given":"Feng-Juan","family":"Han","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,7,24]]},"reference":[{"key":"6840_CR1","doi-asserted-by":"publisher","first-page":"229","DOI":"10.3322\/caac.21834","volume":"74","author":"F Bray","year":"2024","unstructured":"Bray F, Laversanne M, Sung H, Ferlay J, Siegel RL, Soerjomataram I, Jemal A. Global cancer statistics 2022: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin. 2024;74:229\u201363. https:\/\/doi.org\/10.3322\/caac.21834.","journal-title":"CA Cancer J Clin"},{"key":"6840_CR2","doi-asserted-by":"publisher","first-page":"584","DOI":"10.1097\/cm9.0000000000002108","volume":"135","author":"C Xia","year":"2022","unstructured":"Xia C, Dong X, Li H, Cao M, Sun D, He S, Yang F, Yan X, Zhang S, Li N, Chen W. Cancer statistics in China and United States, 2022: profiles, trends, and determinants. Chin Med J. 2022;135:584\u201390. https:\/\/doi.org\/10.1097\/cm9.0000000000002108.","journal-title":"Chin Med J"},{"key":"6840_CR3","doi-asserted-by":"publisher","first-page":"401","DOI":"10.1016\/j.ygyno.2014.04.013","volume":"133","author":"DG Mutch","year":"2014","unstructured":"Mutch DG, Prat J. 2014 FIGO staging for ovarian, fallopian tube and peritoneal cancer. Gynecol Oncol. 2014;133:401\u20134. https:\/\/doi.org\/10.1016\/j.ygyno.2014.04.013.","journal-title":"Gynecol Oncol"},{"key":"6840_CR4","doi-asserted-by":"publisher","DOI":"10.1111\/1471-0528.17904","author":"SM Crawford","year":"2024","unstructured":"Crawford SM, Evans C, Shaw A, Barr CE, Crosbie EJ. Measuring HE4 alongside CA125 for ovarian cancer diagnosis: a pilot clinical study. BJOG. 2024. https:\/\/doi.org\/10.1111\/1471-0528.17904.","journal-title":"BJOG"},{"key":"6840_CR5","doi-asserted-by":"publisher","DOI":"10.7759\/cureus.30561","volume":"14","author":"UM Zamwar","year":"2022","unstructured":"Zamwar UM, Anjankar AP. Aetiology, epidemiology, histopathology, classification, detailed evaluation, and treatment of ovarian cancer. Cureus. 2022;14: e30561. https:\/\/doi.org\/10.7759\/cureus.30561.","journal-title":"Cureus"},{"key":"6840_CR6","doi-asserted-by":"publisher","first-page":"16061","DOI":"10.1038\/nrdp.2016.61","volume":"2","author":"UA Matulonis","year":"2016","unstructured":"Matulonis UA, Sood AK, Fallowfield L, Howitt BE, Sehouli J, Karlan BY. Ovarian cancer. Nat Rev Dis Prim. 2016;2:16061. https:\/\/doi.org\/10.1038\/nrdp.2016.61.","journal-title":"Nat Rev Dis Prim"},{"key":"6840_CR7","doi-asserted-by":"publisher","first-page":"389","DOI":"10.1038\/s41571-024-00881-3","volume":"21","author":"PM Webb","year":"2024","unstructured":"Webb PM, Jordan SJ. Global epidemiology of epithelial ovarian cancer. Nat Rev Clin Oncol. 2024;21:389\u2013400. https:\/\/doi.org\/10.1038\/s41571-024-00881-3.","journal-title":"Nat Rev Clin Oncol"},{"key":"6840_CR8","doi-asserted-by":"publisher","first-page":"663","DOI":"10.1093\/carcin\/bgab033","volume":"42","author":"P Shukla","year":"2021","unstructured":"Shukla P, Singh KK. The mitochondrial landscape of ovarian cancer: emerging insights. Carcinogenesis. 2021;42:663\u201371. https:\/\/doi.org\/10.1093\/carcin\/bgab033.","journal-title":"Carcinogenesis"},{"key":"6840_CR9","doi-asserted-by":"publisher","DOI":"10.1016\/j.bj.2024.100714","author":"R Al-Faze","year":"2024","unstructured":"Al-Faze R, Ahmed HA, El-Atawy MA, Zagloul H, Alshammari EM, Jaremko M, Emwas A-H, Nabil GM, Hanna DH. Mitochondrial dysfunction route as a possible biomarker and therapy target for human cancer. Biomed J. 2024. https:\/\/doi.org\/10.1016\/j.bj.2024.100714.","journal-title":"Biomed J"},{"key":"6840_CR10","doi-asserted-by":"publisher","first-page":"133","DOI":"10.1146\/annurev-biochem-060815-014402","volume":"85","author":"CM Gustafsson","year":"2016","unstructured":"Gustafsson CM, Falkenberg M, Larsson NG. Maintenance and expression of mammalian mitochondrial DNA. Annu Rev Biochem. 2016;85:133\u201360. https:\/\/doi.org\/10.1146\/annurev-biochem-060815-014402.","journal-title":"Annu Rev Biochem"},{"key":"6840_CR11","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1186\/1476-4598-1-9","volume":"1","author":"JS Carew","year":"2002","unstructured":"Carew JS, Huang P. Mitochondrial defects in cancer. Mol Cancer. 2002;1:9. https:\/\/doi.org\/10.1186\/1476-4598-1-9.","journal-title":"Mol Cancer"},{"key":"6840_CR12","doi-asserted-by":"publisher","first-page":"851","DOI":"10.1016\/j.semcancer.2022.02.002","volume":"86","author":"J Greene","year":"2022","unstructured":"Greene J, Segaran A, Lord S. Targeting OXPHOS and the electron transport chain in cancer; molecular and therapeutic implications. Semin Cancer Biol. 2022;86:851\u20139. https:\/\/doi.org\/10.1016\/j.semcancer.2022.02.002.","journal-title":"Semin Cancer Biol"},{"key":"6840_CR13","doi-asserted-by":"publisher","first-page":"1960","DOI":"10.1161\/res.0000000000000104","volume":"118","author":"E Murphy","year":"2016","unstructured":"Murphy E, Ardehali H, Balaban RS, DiLisa F, Dorn GW 2nd, Kitsis RN, Otsu K, Ping P, Rizzuto R, Sack MN, Wallace D, Youle RJ. Mitochondrial function, biology, and role in disease: a scientific statement from the american heart association. Circ Res. 2016;118:1960\u201391. https:\/\/doi.org\/10.1161\/res.0000000000000104.","journal-title":"Circ Res"},{"key":"6840_CR14","doi-asserted-by":"publisher","first-page":"65","DOI":"10.1016\/j.cell.2014.02.049","volume":"157","author":"DR Green","year":"2014","unstructured":"Green DR, Levine B. To be or not to be? How selective autophagy and cell death govern cell fate. Cell. 2014;157:65\u201375. https:\/\/doi.org\/10.1016\/j.cell.2014.02.049.","journal-title":"Cell"},{"key":"6840_CR15","doi-asserted-by":"publisher","DOI":"10.1111\/cpr.13327","volume":"55","author":"C Song","year":"2022","unstructured":"Song C, Pan S, Zhang J, Li N, Geng Q. Mitophagy: a novel perspective for insighting into cancer and cancer treatment. Cell Prolif. 2022;55: e13327. https:\/\/doi.org\/10.1111\/cpr.13327.","journal-title":"Cell Prolif"},{"key":"6840_CR16","doi-asserted-by":"publisher","first-page":"1361289","DOI":"10.3389\/fendo.2024.1361289","volume":"15","author":"W Ju","year":"2024","unstructured":"Ju W, Zhao Y, Yu Y, Zhao S, Xiang S, Lian F. Mechanisms of mitochondrial dysfunction in ovarian aging and potential interventions. Front Endocrinol. 2024;15:1361289. https:\/\/doi.org\/10.3389\/fendo.2024.1361289.","journal-title":"Front Endocrinol"},{"key":"6840_CR17","doi-asserted-by":"publisher","first-page":"2","DOI":"10.1007\/bf02255913","volume":"7","author":"HC Lee","year":"2000","unstructured":"Lee HC, Wei YH. Mitochondrial role in life and death of the cell. J Biomed Sci. 2000;7:2\u201315. https:\/\/doi.org\/10.1007\/bf02255913.","journal-title":"J Biomed Sci"},{"key":"6840_CR18","doi-asserted-by":"publisher","first-page":"532","DOI":"10.1016\/j.bbamcr.2010.10.017","volume":"1813","author":"J Lindsay","year":"2011","unstructured":"Lindsay J, Esposti MD, Gilmore AP. Bcl-2 proteins and mitochondria\u2014Specificity in membrane targeting for death. Biochim et Biophys Acta (BBA) Mol Cell Res. 2011;1813:532\u20139. https:\/\/doi.org\/10.1016\/j.bbamcr.2010.10.017.","journal-title":"Biochim et Biophys Acta (BBA) Mol Cell Res"},{"key":"6840_CR19","doi-asserted-by":"publisher","first-page":"121","DOI":"10.1038\/nrm.2017.95","volume":"19","author":"S Herzig","year":"2018","unstructured":"Herzig S, Shaw RJ. AMPK: guardian of metabolism and mitochondrial homeostasis. Nat Rev Mol Cell Biol. 2018;19:121\u201335. https:\/\/doi.org\/10.1038\/nrm.2017.95.","journal-title":"Nat Rev Mol Cell Biol"},{"key":"6840_CR20","doi-asserted-by":"publisher","first-page":"102","DOI":"10.1038\/s41467-019-13668-3","volume":"11","author":"I Mart\u00ednez-Reyes","year":"2020","unstructured":"Mart\u00ednez-Reyes I, Chandel NS. Mitochondrial TCA cycle metabolites control physiology and disease. Nat Commun. 2020;11:102. https:\/\/doi.org\/10.1038\/s41467-019-13668-3.","journal-title":"Nat Commun"},{"key":"6840_CR21","doi-asserted-by":"publisher","first-page":"82","DOI":"10.1016\/j.omto.2021.08.015","volume":"23","author":"T Wang","year":"2021","unstructured":"Wang T, Ma F, Qian HL. Defueling the cancer: ATP synthase as an emerging target in cancer therapy. Mol Ther Oncolytics. 2021;23:82\u201395. https:\/\/doi.org\/10.1016\/j.omto.2021.08.015.","journal-title":"Mol Ther Oncolytics"},{"key":"6840_CR22","doi-asserted-by":"publisher","first-page":"2236","DOI":"10.1056\/NEJMra1215233","volume":"369","author":"SL Archer","year":"2013","unstructured":"Archer SL. Mitochondrial dynamics\u2013mitochondrial fission and fusion in human diseases. N Engl J Med. 2013;369:2236\u201351. https:\/\/doi.org\/10.1056\/NEJMra1215233.","journal-title":"N Engl J Med"},{"key":"6840_CR23","doi-asserted-by":"publisher","first-page":"101944","DOI":"10.1016\/j.redox.2021.101944","volume":"41","author":"R Quintana-Cabrera","year":"2021","unstructured":"Quintana-Cabrera R, Manjarr\u00e9s-Raza I, Vicente-Guti\u00e9rrez C, Corrado M, Bola\u00f1os JP, Scorrano L. Opa1 relies on cristae preservation and ATP synthase to curtail reactive oxygen species accumulation in mitochondria. Redox Biol. 2021;41:101944. https:\/\/doi.org\/10.1016\/j.redox.2021.101944.","journal-title":"Redox Biol"},{"key":"6840_CR24","doi-asserted-by":"publisher","first-page":"1999","DOI":"10.1007\/s00018-016-2451-3","volume":"74","author":"AP Trotta","year":"2017","unstructured":"Trotta AP, Chipuk JE. Mitochondrial dynamics as regulators of cancer biology. Cell Mol Life Sci. 2017;74:1999\u20132017. https:\/\/doi.org\/10.1007\/s00018-016-2451-3.","journal-title":"Cell Mol Life Sci"},{"key":"6840_CR25","doi-asserted-by":"publisher","first-page":"659","DOI":"10.1091\/mbc.E12-10-0721","volume":"24","author":"OC Los\u00f3n","year":"2013","unstructured":"Los\u00f3n OC, Song Z, Chen H, Chan DC. Fis1, Mff, MiD49, and MiD51 mediate Drp1 recruitment in mitochondrial fission. Mol Biol Cell. 2013;24:659\u201367. https:\/\/doi.org\/10.1091\/mbc.E12-10-0721.","journal-title":"Mol Biol Cell"},{"key":"6840_CR26","doi-asserted-by":"publisher","first-page":"5239","DOI":"10.1038\/s41467-018-07543-w","volume":"9","author":"SC Kamerkar","year":"2018","unstructured":"Kamerkar SC, Kraus F, Sharpe AJ, Pucadyil TJ, Ryan MT. Dynamin-related protein 1 has membrane constricting and severing abilities sufficient for mitochondrial and peroxisomal fission. Nat Commun. 2018;9:5239. https:\/\/doi.org\/10.1038\/s41467-018-07543-w.","journal-title":"Nat Commun"},{"key":"6840_CR27","doi-asserted-by":"publisher","first-page":"834","DOI":"10.1016\/j.cmet.2015.05.007","volume":"21","author":"T Varanita","year":"2015","unstructured":"Varanita T, Soriano ME, Romanello V, Zaglia T, Quintana-Cabrera R, Semenzato M, Menab\u00f2 R, Costa V, Civiletto G, Pesce P, Viscomi C, Zeviani M, Di Lisa F, Mongillo M, Sandri M, Scorrano L. The OPA1-dependent mitochondrial cristae remodeling pathway controls atrophic, apoptotic, and ischemic tissue damage. Cell Metab. 2015;21:834\u201344. https:\/\/doi.org\/10.1016\/j.cmet.2015.05.007.","journal-title":"Cell Metab"},{"key":"6840_CR28","doi-asserted-by":"publisher","first-page":"177","DOI":"10.1016\/j.cell.2006.06.025","volume":"126","author":"C Frezza","year":"2006","unstructured":"Frezza C, Cipolat S, Martins de Brito O, Micaroni M, Beznoussenko GV, Rudka T, Bartoli D, Polishuck RS, Danial NN, De Strooper B, Scorrano L. OPA1 controls apoptotic cristae remodeling independently from mitochondrial fusion. Cell. 2006;126:177\u201389. https:\/\/doi.org\/10.1016\/j.cell.2006.06.025.","journal-title":"Cell"},{"key":"6840_CR29","doi-asserted-by":"publisher","first-page":"695","DOI":"10.1016\/j.molcel.2016.02.019","volume":"61","author":"PD Bhola","year":"2016","unstructured":"Bhola PD, Letai A. Mitochondria-judges and executioners of cell death sentences. Mol Cell. 2016;61:695\u2013704. https:\/\/doi.org\/10.1016\/j.molcel.2016.02.019.","journal-title":"Mol Cell"},{"key":"6840_CR30","doi-asserted-by":"publisher","first-page":"87","DOI":"10.1186\/1756-9966-30-87","volume":"30","author":"RS Wong","year":"2011","unstructured":"Wong RS. Apoptosis in cancer: from pathogenesis to treatment. J Exp Clin Cancer Res. 2011;30:87. https:\/\/doi.org\/10.1186\/1756-9966-30-87.","journal-title":"J Exp Clin Cancer Res"},{"key":"6840_CR31","doi-asserted-by":"publisher","first-page":"156","DOI":"10.1038\/35004029","volume":"2","author":"JC Goldstein","year":"2000","unstructured":"Goldstein JC, Waterhouse NJ, Juin P, Evan GI, Green DR. The coordinate release of cytochrome c during apoptosis is rapid, complete and kinetically invariant. Nat Cell Biol. 2000;2:156\u201362. https:\/\/doi.org\/10.1038\/35004029.","journal-title":"Nat Cell Biol"},{"key":"6840_CR32","doi-asserted-by":"publisher","first-page":"47","DOI":"10.1038\/nrm2308","volume":"9","author":"RJ Youle","year":"2008","unstructured":"Youle RJ, Strasser A. The BCL-2 protein family: opposing activities that mediate cell death. Nat Rev Mol Cell Biol. 2008;9:47\u201359. https:\/\/doi.org\/10.1038\/nrm2308.","journal-title":"Nat Rev Mol Cell Biol"},{"key":"6840_CR33","doi-asserted-by":"publisher","first-page":"55","DOI":"10.1016\/j.ejmech.2015.04.040","volume":"97","author":"AM Pisoschi","year":"2015","unstructured":"Pisoschi AM, Pop A. The role of antioxidants in the chemistry of oxidative stress: a review. Eur J Med Chem. 2015;97:55\u201374. https:\/\/doi.org\/10.1016\/j.ejmech.2015.04.040.","journal-title":"Eur J Med Chem"},{"key":"6840_CR34","doi-asserted-by":"publisher","first-page":"425","DOI":"10.1002\/ejhf.1320","volume":"21","author":"A van der Pol","year":"2019","unstructured":"van der Pol A, van Gilst WH, Voors AA, van der Meer P. Treating oxidative stress in heart failure: past, present and future. Eur J Heart Fail. 2019;21:425\u201335. https:\/\/doi.org\/10.1002\/ejhf.1320.","journal-title":"Eur J Heart Fail"},{"key":"6840_CR35","doi-asserted-by":"publisher","first-page":"8416763","DOI":"10.1155\/2017\/8416763","volume":"2017","author":"G Pizzino","year":"2017","unstructured":"Pizzino G, Irrera N, Cucinotta M, Pallio G, Mannino F, Arcoraci V, Squadrito F, Altavilla D, Bitto A. Oxidative stress: harms and benefits for human health. Oxid Med Cell Longev. 2017;2017:8416763. https:\/\/doi.org\/10.1155\/2017\/8416763.","journal-title":"Oxid Med Cell Longev"},{"key":"6840_CR36","doi-asserted-by":"publisher","DOI":"10.3390\/antiox10111824","author":"G Napolitano","year":"2021","unstructured":"Napolitano G, Fasciolo G, Venditti P. Mitochondrial management of reactive oxygen species. Antioxidants. 2021. https:\/\/doi.org\/10.3390\/antiox10111824.","journal-title":"Antioxidants"},{"key":"6840_CR37","doi-asserted-by":"publisher","first-page":"R170","DOI":"10.1016\/j.cub.2018.01.004","volume":"28","author":"S Pickles","year":"2018","unstructured":"Pickles S, Vigi\u00e9 P, Youle RJ. Mitophagy and quality control mechanisms in mitochondrial maintenance. Curr Biol. 2018;28:R170-r185. https:\/\/doi.org\/10.1016\/j.cub.2018.01.004.","journal-title":"Curr Biol"},{"key":"6840_CR38","doi-asserted-by":"publisher","DOI":"10.15252\/embj.2020104705","volume":"40","author":"M Onishi","year":"2021","unstructured":"Onishi M, Yamano K, Sato M, Matsuda N, Okamoto K. Molecular mechanisms and physiological functions of mitophagy. Embo J. 2021;40: e104705. https:\/\/doi.org\/10.15252\/embj.2020104705.","journal-title":"Embo J"},{"key":"6840_CR39","doi-asserted-by":"publisher","first-page":"2047","DOI":"10.1038\/s42255-023-00930-8","volume":"5","author":"A Picca","year":"2023","unstructured":"Picca A, Faitg J, Auwerx J, Ferrucci L, D\u2019Amico D. Mitophagy in human health, ageing and disease. Nat Metab. 2023;5:2047\u201361. https:\/\/doi.org\/10.1038\/s42255-023-00930-8.","journal-title":"Nat Metab"},{"key":"6840_CR40","doi-asserted-by":"publisher","first-page":"3817","DOI":"10.1007\/s00018-021-03774-1","volume":"78","author":"LP Poole","year":"2021","unstructured":"Poole LP, Macleod KF. Mitophagy in tumorigenesis and metastasis. Cell Mol Life Sci. 2021;78:3817\u201351. https:\/\/doi.org\/10.1007\/s00018-021-03774-1.","journal-title":"Cell Mol Life Sci"},{"key":"6840_CR41","doi-asserted-by":"publisher","first-page":"1315","DOI":"10.1038\/onc.2016.302","volume":"36","author":"JP Bernardini","year":"2017","unstructured":"Bernardini JP, Lazarou M, Dewson G. Parkin and mitophagy in cancer. Oncogene. 2017;36:1315\u201327. https:\/\/doi.org\/10.1038\/onc.2016.302.","journal-title":"Oncogene"},{"key":"6840_CR42","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1080\/15548627.2019.1603547","volume":"16","author":"Y Xu","year":"2020","unstructured":"Xu Y, Shen J, Ran Z. Emerging views of mitophagy in immunity and autoimmune diseases. Autophagy. 2020;16:3\u201317. https:\/\/doi.org\/10.1080\/15548627.2019.1603547.","journal-title":"Autophagy"},{"key":"6840_CR43","doi-asserted-by":"publisher","first-page":"304","DOI":"10.1038\/s41392-023-01503-7","volume":"8","author":"S Wang","year":"2023","unstructured":"Wang S, Long H, Hou L, Feng B, Ma Z, Wu Y, Zeng Y, Cai J, Zhang DW, Zhao G. The mitophagy pathway and its implications in human diseases. Signal Transduct Target Ther. 2023;8:304. https:\/\/doi.org\/10.1038\/s41392-023-01503-7.","journal-title":"Signal Transduct Target Ther"},{"key":"6840_CR44","doi-asserted-by":"publisher","DOI":"10.3390\/ijms21165598","author":"Y Luo","year":"2020","unstructured":"Luo Y, Ma J, Lu W. The significance of mitochondrial dysfunction in cancer. Int J Mol Sci. 2020. https:\/\/doi.org\/10.3390\/ijms21165598.","journal-title":"Int J Mol Sci"},{"key":"6840_CR45","doi-asserted-by":"publisher","first-page":"803","DOI":"10.1111\/febs.13603","volume":"283","author":"E Giampazolias","year":"2016","unstructured":"Giampazolias E, Tait SW. Mitochondria and the hallmarks of cancer. Febs j. 2016;283:803\u201314. https:\/\/doi.org\/10.1111\/febs.13603.","journal-title":"Febs j"},{"key":"6840_CR46","doi-asserted-by":"publisher","first-page":"667","DOI":"10.1016\/j.molcel.2016.02.011","volume":"61","author":"W-X Zong","year":"2016","unstructured":"Zong W-X, Rabinowitz JD, White E. Mitochondria and cancer. Mol Cell. 2016;61:667\u201376. https:\/\/doi.org\/10.1016\/j.molcel.2016.02.011.","journal-title":"Mol Cell"},{"key":"6840_CR47","doi-asserted-by":"publisher","first-page":"555","DOI":"10.1016\/j.cell.2016.07.002","volume":"166","author":"S Vyas","year":"2016","unstructured":"Vyas S, Zaganjor E, Haigis MC. Mitochondria and cancer. Cell. 2016;166:555\u201366. https:\/\/doi.org\/10.1016\/j.cell.2016.07.002.","journal-title":"Cell"},{"key":"6840_CR48","doi-asserted-by":"publisher","first-page":"661","DOI":"10.1007\/s13167-020-00224-z","volume":"11","author":"N Li","year":"2020","unstructured":"Li N, Li H, Wang Y, Cao L, Zhan X. Quantitative proteomics revealed energy metabolism pathway alterations in human epithelial ovarian carcinoma and their regulation by the antiparasite drug ivermectin: data interpretation in the context of 3P medicine. Epma J. 2020;11:661\u201394. https:\/\/doi.org\/10.1007\/s13167-020-00224-z.","journal-title":"Epma J"},{"key":"6840_CR49","doi-asserted-by":"publisher","first-page":"153","DOI":"10.1007\/s13167-019-00170-5","volume":"10","author":"N Li","year":"2019","unstructured":"Li N, Zhan X. Signaling pathway network alterations in human ovarian cancers identified with quantitative mitochondrial proteomics. Epma J. 2019;10:153\u201372. https:\/\/doi.org\/10.1007\/s13167-019-00170-5.","journal-title":"Epma J"},{"key":"6840_CR50","doi-asserted-by":"publisher","first-page":"471","DOI":"10.1002\/mas.21618","volume":"39","author":"N Li","year":"2020","unstructured":"Li N, Zhan X. Mass spectrometry-based mitochondrial proteomics in human ovarian cancers. Mass Spectrom Rev. 2020;39:471\u201398. https:\/\/doi.org\/10.1002\/mas.21618.","journal-title":"Mass Spectrom Rev"},{"key":"6840_CR51","doi-asserted-by":"publisher","first-page":"125","DOI":"10.1016\/j.semcancer.2017.05.001","volume":"47","author":"AR Choudhury","year":"2017","unstructured":"Choudhury AR, Singh KK. Mitochondrial determinants of cancer health disparities. Semin Cancer Biol. 2017;47:125\u201346. https:\/\/doi.org\/10.1016\/j.semcancer.2017.05.001.","journal-title":"Semin Cancer Biol"},{"key":"6840_CR52","doi-asserted-by":"publisher","first-page":"90","DOI":"10.1016\/j.cmet.2021.12.001","volume":"34","author":"PK Parida","year":"2022","unstructured":"Parida PK, Marquez-Palencia M, Nair V, Kaushik AK, Kim K, Sudderth J, Quesada-Diaz E, Cajigas A, Vemireddy V, Gonzalez-Ericsson PI, Sanders ME, Mobley BC, Huffman K, Sahoo S, Alluri P, Lewis C, Peng Y, Bachoo RM, Arteaga CL, Hanker AB, DeBerardinis RJ, Malladi S. Metabolic diversity within breast cancer brain-tropic cells determines metastatic fitness. Cell Metab. 2022;34:90-105.e107. https:\/\/doi.org\/10.1016\/j.cmet.2021.12.001.","journal-title":"Cell Metab"},{"key":"6840_CR53","doi-asserted-by":"publisher","first-page":"746","DOI":"10.1038\/s41586-024-08146-w","volume":"635","author":"KW Ryu","year":"2024","unstructured":"Ryu KW, Fung TS, Baker DC, Saoi M, Park J, Febres-Aldana CA, Aly RG, Cui R, Sharma A, Fu Y, Jones OL, Cai X, Pasolli HA, Cross JR, Rudin CM, Thompson CB. Cellular ATP demand creates metabolically distinct subpopulations of mitochondria. Nature. 2024;635:746\u201354. https:\/\/doi.org\/10.1038\/s41586-024-08146-w.","journal-title":"Nature"},{"key":"6840_CR54","doi-asserted-by":"publisher","first-page":"893","DOI":"10.1038\/s43018-023-00563-6","volume":"4","author":"PK Parida","year":"2023","unstructured":"Parida PK, Marquez-Palencia M, Ghosh S, Khandelwal N, Kim K, Nair V, Liu XZ, Vu HS, Zacharias LG, Gonzalez-Ericsson PI, Sanders ME, Mobley BC, McDonald JG, Lemoff A, Peng Y, Lewis C, Vale G, Halberg N, Arteaga CL, Hanker AB, DeBerardinis RJ, Malladi S. Limiting mitochondrial plasticity by targeting DRP1 induces metabolic reprogramming and reduces breast cancer brain metastases. Nat Cancer. 2023;4:893\u2013907. https:\/\/doi.org\/10.1038\/s43018-023-00563-6.","journal-title":"Nat Cancer"},{"key":"6840_CR55","doi-asserted-by":"publisher","first-page":"519","DOI":"10.1085\/jgp.8.6.519","volume":"8","author":"O Warburg","year":"1927","unstructured":"Warburg O, Wind F, Negelein E. The metabolism of tumors in the body. J Gen Physiol. 1927;8:519\u201330. https:\/\/doi.org\/10.1085\/jgp.8.6.519.","journal-title":"J Gen Physiol"},{"key":"6840_CR56","doi-asserted-by":"publisher","first-page":"309","DOI":"10.1126\/science.123.3191.309","volume":"123","author":"O Warburg","year":"1956","unstructured":"Warburg O. On the origin of cancer cells. Science. 1956;123:309\u201314. https:\/\/doi.org\/10.1126\/science.123.3191.309.","journal-title":"Science"},{"key":"6840_CR57","doi-asserted-by":"publisher","DOI":"10.3390\/cancers10090337","author":"AP Nayak","year":"2018","unstructured":"Nayak AP, Kapur A, Barroilhet L, Patankar MS. Oxidative phosphorylation: a target for novel therapeutic strategies against ovarian cancer. Cancers. 2018. https:\/\/doi.org\/10.3390\/cancers10090337.","journal-title":"Cancers"},{"key":"6840_CR58","doi-asserted-by":"publisher","first-page":"646","DOI":"10.1016\/j.cell.2011.02.013","volume":"144","author":"D Hanahan","year":"2011","unstructured":"Hanahan D, Weinberg RA. Hallmarks of cancer: the next generation. Cell. 2011;144:646\u201374. https:\/\/doi.org\/10.1016\/j.cell.2011.02.013.","journal-title":"Cell"},{"key":"6840_CR59","doi-asserted-by":"publisher","first-page":"267","DOI":"10.1038\/nrc2817","volume":"10","author":"DA Tennant","year":"2010","unstructured":"Tennant DA, Dur\u00e1n RV, Gottlieb E. Targeting metabolic transformation for cancer therapy. Nat Rev Cancer. 2010;10:267\u201377. https:\/\/doi.org\/10.1038\/nrc2817.","journal-title":"Nat Rev Cancer"},{"key":"6840_CR60","doi-asserted-by":"publisher","first-page":"441","DOI":"10.1146\/annurev-cellbio-092910-154237","volume":"27","author":"SY Lunt","year":"2011","unstructured":"Lunt SY, Vander Heiden MG. Aerobic glycolysis: meeting the metabolic requirements of cell proliferation. Annu Rev Cell Dev Biol. 2011;27:441\u201364. https:\/\/doi.org\/10.1146\/annurev-cellbio-092910-154237.","journal-title":"Annu Rev Cell Dev Biol"},{"key":"6840_CR61","doi-asserted-by":"publisher","first-page":"329","DOI":"10.1016\/j.radonc.2009.06.025","volume":"92","author":"O Feron","year":"2009","unstructured":"Feron O. Pyruvate into lactate and back: from the Warburg effect to symbiotic energy fuel exchange in cancer cells. Radiother Oncol. 2009;92:329\u201333. https:\/\/doi.org\/10.1016\/j.radonc.2009.06.025.","journal-title":"Radiother Oncol"},{"key":"6840_CR62","doi-asserted-by":"publisher","first-page":"8760","DOI":"10.1038\/s41598-017-09206-0","volume":"7","author":"S Dar","year":"2017","unstructured":"Dar S, Chhina J, Mert I, Chitale D, Buekers T, Kaur H, Giri S, Munkarah A, Rattan R. Bioenergetic adaptations in chemoresistant ovarian cancer cells. Sci Rep. 2017;7:8760. https:\/\/doi.org\/10.1038\/s41598-017-09206-0.","journal-title":"Sci Rep"},{"key":"6840_CR63","doi-asserted-by":"publisher","first-page":"1029","DOI":"10.1126\/science.1160809","volume":"324","author":"MG Vander Heiden","year":"2009","unstructured":"Vander Heiden MG, Cantley LC, Thompson CB. Understanding the Warburg effect: the metabolic requirements of cell proliferation. Science. 2009;324:1029\u201333. https:\/\/doi.org\/10.1126\/science.1160809.","journal-title":"Science"},{"key":"6840_CR64","doi-asserted-by":"publisher","first-page":"584","DOI":"10.1016\/j.mito.2010.08.002","volume":"10","author":"MV Berridge","year":"2010","unstructured":"Berridge MV, Herst PM, Tan AS. Metabolic flexibility and cell hierarchy in metastatic cancer. Mitochondrion. 2010;10:584\u20138. https:\/\/doi.org\/10.1016\/j.mito.2010.08.002.","journal-title":"Mitochondrion"},{"key":"6840_CR65","doi-asserted-by":"publisher","first-page":"931","DOI":"10.1038\/nrd4002","volume":"12","author":"C Gorrini","year":"2013","unstructured":"Gorrini C, Harris IS, Mak TW. Modulation of oxidative stress as an anticancer strategy. Nat Rev Drug Discov. 2013;12:931\u201347. https:\/\/doi.org\/10.1038\/nrd4002.","journal-title":"Nat Rev Drug Discov"},{"key":"6840_CR66","doi-asserted-by":"publisher","first-page":"1055","DOI":"10.3892\/ijo.2018.4476","volume":"53","author":"Y Xu","year":"2018","unstructured":"Xu Y, Gao W, Zhang Y, Wu S, Liu Y, Deng X, Xie L, Yang J, Yu H, Su J, Sun L. ABT737 reverses cisplatin resistance by targeting glucose metabolism of human ovarian cancer cells. Int J Oncol. 2018;53:1055\u201368. https:\/\/doi.org\/10.3892\/ijo.2018.4476.","journal-title":"Int J Oncol"},{"key":"6840_CR67","doi-asserted-by":"publisher","first-page":"1542","DOI":"10.1038\/cdd.2016.39","volume":"23","author":"DS Matassa","year":"2016","unstructured":"Matassa DS, Amoroso MR, Lu H, Avolio R, Arzeni D, Procaccini C, Faicchia D, Maddalena F, Simeon V, Agliarulo I, Zanini E, Mazzoccoli C, Recchi C, Stronach E, Marone G, Gabra H, Matarese G, Landriscina M, Esposito F. Oxidative metabolism drives inflammation-induced platinum resistance in human ovarian cancer. Cell Death Differ. 2016;23:1542\u201354. https:\/\/doi.org\/10.1038\/cdd.2016.39.","journal-title":"Cell Death Differ"},{"key":"6840_CR68","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1016\/j.cmet.2007.10.002","volume":"7","author":"RJ DeBerardinis","year":"2008","unstructured":"DeBerardinis RJ, Lum JJ, Hatzivassiliou G, Thompson CB. The biology of cancer: metabolic reprogramming fuels cell growth and proliferation. Cell Metab. 2008;7:11\u201320. https:\/\/doi.org\/10.1016\/j.cmet.2007.10.002.","journal-title":"Cell Metab"},{"key":"6840_CR69","doi-asserted-by":"publisher","first-page":"156","DOI":"10.1016\/j.canlet.2014.04.001","volume":"356","author":"J Lu","year":"2015","unstructured":"Lu J, Tan M, Cai Q. The Warburg effect in tumor progression: mitochondrial oxidative metabolism as an anti-metastasis mechanism. Cancer Lett. 2015;356:156\u201364. https:\/\/doi.org\/10.1016\/j.canlet.2014.04.001.","journal-title":"Cancer Lett"},{"key":"6840_CR70","doi-asserted-by":"publisher","first-page":"4305","DOI":"10.18632\/oncotarget.2010","volume":"5","author":"A Past\u00f2","year":"2014","unstructured":"Past\u00f2 A, Bellio C, Pilotto G, Ciminale V, Silic-Benussi M, Guzzo G, Rasola A, Frasson C, Nardo G, Zulato E, Nicoletto MO, Manicone M, Indraccolo S, Amadori A. Cancer stem cells from epithelial ovarian cancer patients privilege oxidative phosphorylation, and resist glucose deprivation. Oncotarget. 2014;5:4305\u201319. https:\/\/doi.org\/10.18632\/oncotarget.2010.","journal-title":"Oncotarget"},{"key":"6840_CR71","doi-asserted-by":"publisher","first-page":"728","DOI":"10.1002\/msb.20134892","volume":"10","author":"L Yang","year":"2014","unstructured":"Yang L, Moss T, Mangala LS, Marini J, Zhao H, Wahlig S, Armaiz-Pena G, Jiang D, Achreja A, Win J, Roopaimoole R, Rodriguez-Aguayo C, Mercado-Uribe I, Lopez-Berestein G, Liu J, Tsukamoto T, Sood AK, Ram PT, Nagrath D. Metabolic shifts toward glutamine regulate tumor growth, invasion and bioenergetics in ovarian cancer. Mol Syst Biol. 2014;10:728. https:\/\/doi.org\/10.1002\/msb.20134892.","journal-title":"Mol Syst Biol"},{"key":"6840_CR72","doi-asserted-by":"publisher","first-page":"156","DOI":"10.1016\/j.cmet.2018.09.002","volume":"29","author":"G Gentric","year":"2019","unstructured":"Gentric G, Kieffer Y, Mieulet V, Goundiam O, Bonneau C, Nemati F, Hurbain I, Raposo G, Popova T, Stern MH, Lallemand-Breitenbach V, M\u00fcller S, Ca\u00f1eque T, Rodriguez R, Vincent-Salomon A, de Th\u00e9 H, Rossignol R, Mechta-Grigoriou F. PML-regulated mitochondrial metabolism enhances chemosensitivity in human ovarian cancers. Cell Metab. 2019;29:156-173.e110. https:\/\/doi.org\/10.1016\/j.cmet.2018.09.002.","journal-title":"Cell Metab"},{"key":"6840_CR73","doi-asserted-by":"publisher","DOI":"10.3390\/cancers14061399","author":"SLE Compton","year":"2022","unstructured":"Compton SLE, Grieco JP, Gollamudi B, Bae E, Van Mullekom JH, Schmelz EM. Metabolic reprogramming of ovarian cancer spheroids during adhesion. Cancers. 2022. https:\/\/doi.org\/10.3390\/cancers14061399.","journal-title":"Cancers"},{"key":"6840_CR74","doi-asserted-by":"publisher","first-page":"1043670","DOI":"10.3389\/fonc.2022.1043670","volume":"12","author":"JP Grieco","year":"2022","unstructured":"Grieco JP, Compton SLE, Bano N, Brookover L, Nichenko AS, Drake JC, Schmelz EM. Mitochondrial plasticity supports proliferative outgrowth and invasion of ovarian cancer spheroids during adhesion. Front Oncol. 2022;12:1043670. https:\/\/doi.org\/10.3389\/fonc.2022.1043670.","journal-title":"Front Oncol"},{"key":"6840_CR75","doi-asserted-by":"publisher","first-page":"22","DOI":"10.1186\/s13048-023-01340-w","volume":"17","author":"S Liu","year":"2024","unstructured":"Liu S, Ding D, Liu F, Guo Y, Xie L, Han FJ. Exploring the causal role of multiple metabolites on ovarian cancer: a two sample Mendelian randomization study. J Ovarian Res. 2024;17:22. https:\/\/doi.org\/10.1186\/s13048-023-01340-w.","journal-title":"J Ovarian Res"},{"key":"6840_CR76","doi-asserted-by":"publisher","first-page":"2017","DOI":"10.1007\/s11427-021-2048-2","volume":"65","author":"X Pei","year":"2022","unstructured":"Pei X, Li KY, Shen Y, Li JT, Lei MZ, Fang CY, Lu HJ, Yang HJ, Wen W, Yin M, Qu J, Lei QY. Palmitoylation of MDH2 by ZDHHC18 activates mitochondrial respiration and accelerates ovarian cancer growth. Sci China Life Sci. 2022;65:2017\u201330. https:\/\/doi.org\/10.1007\/s11427-021-2048-2.","journal-title":"Sci China Life Sci"},{"key":"6840_CR77","doi-asserted-by":"publisher","first-page":"769196","DOI":"10.3389\/fonc.2021.769196","volume":"11","author":"L Xia","year":"2021","unstructured":"Xia L, Zhang H, Wang X, Zhang X, Nie K. The role of succinic acid metabolism in ovarian cancer. Front Oncol. 2021;11:769196. https:\/\/doi.org\/10.3389\/fonc.2021.769196.","journal-title":"Front Oncol"},{"key":"6840_CR78","doi-asserted-by":"publisher","first-page":"1710","DOI":"10.1158\/1541-7786.Mcr-18-1233","volume":"17","author":"ES Dahl","year":"2019","unstructured":"Dahl ES, Buj R, Leon KE, Newell JM, Imamura Y, Bitler BG, Snyder NW, Aird KM. Targeting IDH1 as a prosenescent therapy in high-grade serous ovarian cancer. Mol Cancer Res. 2019;17:1710\u201320. https:\/\/doi.org\/10.1158\/1541-7786.Mcr-18-1233.","journal-title":"Mol Cancer Res"},{"key":"6840_CR79","doi-asserted-by":"publisher","first-page":"21","DOI":"10.1186\/2049-3002-2-21","volume":"2","author":"PP Aspuria","year":"2014","unstructured":"Aspuria PP, Lunt SY, V\u00e4remo L, Vergnes L, Gozo M, Beach JA, Salumbides B, Reue K, Wiedemeyer WR, Nielsen J, Karlan BY, Orsulic S. Succinate dehydrogenase inhibition leads to epithelial-mesenchymal transition and reprogrammed carbon metabolism. Cancer Metab. 2014;2:21. https:\/\/doi.org\/10.1186\/2049-3002-2-21.","journal-title":"Cancer Metab"},{"key":"6840_CR80","doi-asserted-by":"publisher","first-page":"115","DOI":"10.1186\/s13048-014-0115-1","volume":"7","author":"L Chen","year":"2014","unstructured":"Chen L, Liu T, Zhang S, Zhou J, Wang Y, Di W. Succinate dehydrogenase subunit B inhibits the AMPK-HIF-1\u03b1 pathway in human ovarian cancer in vitro. J Ovarian Res. 2014;7:115. https:\/\/doi.org\/10.1186\/s13048-014-0115-1.","journal-title":"J Ovarian Res"},{"key":"6840_CR81","doi-asserted-by":"publisher","first-page":"93","DOI":"10.1016\/j.trecan.2020.10.014","volume":"7","author":"P Shukla","year":"2021","unstructured":"Shukla P, Singh KK. Uncovering mitochondrial determinants of racial disparities in ovarian cancer. Trends Cancer. 2021;7:93\u20137. https:\/\/doi.org\/10.1016\/j.trecan.2020.10.014.","journal-title":"Trends Cancer"},{"key":"6840_CR82","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1007\/s00109-021-02150-7","volume":"100","author":"R Banerjee","year":"2022","unstructured":"Banerjee R, Mukherjee A, Nagotu S. Mitochondrial dynamics and its impact on human health and diseases: inside the DRP1 blackbox. J Mol Med. 2022;100:1\u201321. https:\/\/doi.org\/10.1007\/s00109-021-02150-7.","journal-title":"J Mol Med"},{"key":"6840_CR83","doi-asserted-by":"publisher","first-page":"1062","DOI":"10.1126\/science.1219855","volume":"337","author":"RJ Youle","year":"2012","unstructured":"Youle RJ, van der Bliek AM. Mitochondrial fission, fusion, and stress. Science. 2012;337:1062\u20135. https:\/\/doi.org\/10.1126\/science.1219855.","journal-title":"Science"},{"key":"6840_CR84","doi-asserted-by":"publisher","DOI":"10.3390\/cancers11091350","author":"A Signorile","year":"2019","unstructured":"Signorile A, De Rasmo D, Cormio A, Musicco C, Rossi R, Fortarezza F, Palese LL, Loizzi V, Resta L, Scillitani G, Cicinelli E, Simonetti F, Ferretta A, Russo S, Tufaro A, Cormio G. Human ovarian cancer tissue exhibits increase of mitochondrial biogenesis and cristae remodeling. Cancers. 2019. https:\/\/doi.org\/10.3390\/cancers11091350.","journal-title":"Cancers"},{"key":"6840_CR85","doi-asserted-by":"publisher","first-page":"55","DOI":"10.1016\/s1534-5807(01)00116-2","volume":"2","author":"L Scorrano","year":"2002","unstructured":"Scorrano L, Ashiya M, Buttle K, Weiler S, Oakes SA, Mannella CA, Korsmeyer SJ. A distinct pathway remodels mitochondrial cristae and mobilizes cytochrome c during apoptosis. Dev Cell. 2002;2:55\u201367. https:\/\/doi.org\/10.1016\/s1534-5807(01)00116-2.","journal-title":"Dev Cell"},{"key":"6840_CR86","doi-asserted-by":"publisher","first-page":"728","DOI":"10.1002\/cbin.11148","volume":"43","author":"ES Snigirevskaya","year":"2019","unstructured":"Snigirevskaya ES, Komissarchik YY. Ultrastructural traits of apoptosis. Cell Biol Int. 2019;43:728\u201338. https:\/\/doi.org\/10.1002\/cbin.11148.","journal-title":"Cell Biol Int"},{"key":"6840_CR87","doi-asserted-by":"publisher","first-page":"501","DOI":"10.1146\/annurev-biochem-062917-012739","volume":"89","author":"S Deshwal","year":"2020","unstructured":"Deshwal S, Fiedler KU, Langer T. Mitochondrial proteases: multifaceted regulators of mitochondrial plasticity. Annu Rev Biochem. 2020;89:501\u201328. https:\/\/doi.org\/10.1146\/annurev-biochem-062917-012739.","journal-title":"Annu Rev Biochem"},{"key":"6840_CR88","doi-asserted-by":"publisher","first-page":"626117","DOI":"10.3389\/fcell.2021.626117","volume":"9","author":"R Gilkerson","year":"2021","unstructured":"Gilkerson R, De La Torre P, St VS. Mitochondrial OMA1 and OPA1 as gatekeepers of organellar structure\/function and cellular stress response. Front Cell Dev Biol. 2021;9:626117. https:\/\/doi.org\/10.3389\/fcell.2021.626117.","journal-title":"Front Cell Dev Biol"},{"key":"6840_CR89","doi-asserted-by":"publisher","DOI":"10.3390\/ijms23031320","author":"M Cheng","year":"2022","unstructured":"Cheng M, Yu H, Kong Q, Wang B, Shen L, Dong D, Sun L. The mitochondrial PHB2\/OMA1\/DELE1 pathway cooperates with endoplasmic reticulum stress to facilitate the response to chemotherapeutics in ovarian cancer. Int J Mol Sci. 2022. https:\/\/doi.org\/10.3390\/ijms23031320.","journal-title":"Int J Mol Sci"},{"key":"6840_CR90","doi-asserted-by":"publisher","DOI":"10.1038\/s44319-024-00232-4","author":"Z Javed","year":"2024","unstructured":"Javed Z, Shin DH, Pan W, White SR, Elhaw AT, Kim YS, Kamlapurkar S, Cheng YY, Benson JC, Abdelnaby AE, Pha\u00ebton R, Wang HG, Yang S, Sullivan MLG, St Croix CM, Watkins SC, Mullett SJ, Gelhaus SL, Lee N, Coffman LG, Aird KM, Trebak M, Mythreye K, Walter V, Hempel N. Drp1 splice variants regulate ovarian cancer mitochondrial dynamics and tumor progression. EMBO Rep. 2024. https:\/\/doi.org\/10.1038\/s44319-024-00232-4.","journal-title":"EMBO Rep"},{"key":"6840_CR91","doi-asserted-by":"publisher","first-page":"7358","DOI":"10.7150\/jca.61379","volume":"12","author":"GP Zou","year":"2021","unstructured":"Zou GP, Yu CX, Shi SL, Li QG, Wang XH, Qu XH, Yang ZJ, Yao WR, Yan DD, Jiang LP, Wan YY, Han XJ. Mitochondrial dynamics mediated by DRP1 and MFN2 contributes to cisplatin chemoresistance in human ovarian cancer SKOV3 cells. J Cancer. 2021;12:7358\u201373. https:\/\/doi.org\/10.7150\/jca.61379.","journal-title":"J Cancer"},{"key":"6840_CR92","doi-asserted-by":"publisher","first-page":"3049","DOI":"10.18632\/oncotarget.13829","volume":"8","author":"CW Wang","year":"2017","unstructured":"Wang CW, Hsu WH, Tai CJ. Antimetastatic effects of cordycepin mediated by the inhibition of mitochondrial activity and estrogen-related receptor \u03b1 in human ovarian carcinoma cells. Oncotarget. 2017;8:3049\u201358. https:\/\/doi.org\/10.18632\/oncotarget.13829.","journal-title":"Oncotarget"},{"key":"6840_CR93","doi-asserted-by":"publisher","first-page":"105","DOI":"10.1016\/j.tem.2015.12.001","volume":"27","author":"T Wai","year":"2016","unstructured":"Wai T, Langer T. Mitochondrial dynamics and metabolic regulation. Trends Endocrinol Metab. 2016;27:105\u201317. https:\/\/doi.org\/10.1016\/j.tem.2015.12.001.","journal-title":"Trends Endocrinol Metab"},{"key":"6840_CR94","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1111\/nyas.12883","volume":"1350","author":"B Kong","year":"2015","unstructured":"Kong B, Tsuyoshi H, Orisaka M, Shieh DB, Yoshida Y, Tsang BK. Mitochondrial dynamics regulating chemoresistance in gynecological cancers. Ann N Y Acad Sci. 2015;1350:1\u201316. https:\/\/doi.org\/10.1111\/nyas.12883.","journal-title":"Ann N Y Acad Sci"},{"key":"6840_CR95","doi-asserted-by":"publisher","first-page":"27134","DOI":"10.1074\/jbc.M114.594812","volume":"289","author":"B Kong","year":"2014","unstructured":"Kong B, Wang Q, Fung E, Xue K, Tsang BK. p53 is required for cisplatin-induced processing of the mitochondrial fusion protein L-Opa1 that is mediated by the mitochondrial metallopeptidase Oma1 in gynecologic cancers. J Biol Chem. 2014;289:27134\u201345. https:\/\/doi.org\/10.1074\/jbc.M114.594812.","journal-title":"J Biol Chem"},{"key":"6840_CR96","doi-asserted-by":"publisher","first-page":"60021","DOI":"10.18632\/oncotarget.11047","volume":"7","author":"DK Tanwar","year":"2016","unstructured":"Tanwar DK, Parker DJ, Gupta P, Spurlock B, Alvarez RD, Basu MK, Mitra K. Crosstalk between the mitochondrial fission protein, Drp1, and the cell cycle is identified across various cancer types and can impact survival of epithelial ovarian cancer patients. Oncotarget. 2016;7:60021\u201337. https:\/\/doi.org\/10.18632\/oncotarget.11047.","journal-title":"Oncotarget"},{"key":"6840_CR97","doi-asserted-by":"publisher","first-page":"600113","DOI":"10.3389\/fonc.2020.600113","volume":"10","author":"JP Grieco","year":"2020","unstructured":"Grieco JP, Allen ME, Perry JB, Wang Y, Song Y, Rohani A, Compton SLE, Smyth JW, Swami NS, Brown DA, Schmelz EM. Progression-mediated changes in mitochondrial morphology promotes adaptation to hypoxic peritoneal conditions in serous ovarian cancer. Front Oncol. 2020;10:600113. https:\/\/doi.org\/10.3389\/fonc.2020.600113.","journal-title":"Front Oncol"},{"key":"6840_CR98","doi-asserted-by":"publisher","first-page":"372","DOI":"10.1038\/nature21077","volume":"542","author":"YL Cao","year":"2017","unstructured":"Cao YL, Meng S, Chen Y, Feng JX, Gu DD, Yu B, Li YJ, Yang JY, Liao S, Chan DC, Gao S. MFN1 structures reveal nucleotide-triggered dimerization critical for mitochondrial fusion. Nature. 2017;542:372\u20136. https:\/\/doi.org\/10.1038\/nature21077.","journal-title":"Nature"},{"key":"6840_CR99","doi-asserted-by":"publisher","first-page":"107537","DOI":"10.1016\/j.isci.2023.107537","volume":"26","author":"D Ghosh","year":"2023","unstructured":"Ghosh D, Pakhira S, Ghosh DD, Roychoudhury S, Roy SS. Ets1 facilitates EMT\/invasion through Drp1-mediated mitochondrial fragmentation in ovarian cancer. IScience. 2023;26:107537. https:\/\/doi.org\/10.1016\/j.isci.2023.107537.","journal-title":"IScience"},{"key":"6840_CR100","doi-asserted-by":"publisher","first-page":"4821","DOI":"10.1007\/s00018-021-03818-6","volume":"78","author":"P Prasad","year":"2021","unstructured":"Prasad P, Ghosh S, Roy SS. Glutamine deficiency promotes stemness and chemoresistance in tumor cells through DRP1-induced mitochondrial fragmentation. Cell Mol Life Sci. 2021;78:4821\u201345. https:\/\/doi.org\/10.1007\/s00018-021-03818-6.","journal-title":"Cell Mol Life Sci"},{"key":"6840_CR101","doi-asserted-by":"publisher","first-page":"2662","DOI":"10.1091\/mbc.E16-05-0286","volume":"27","author":"B Cunniff","year":"2016","unstructured":"Cunniff B, McKenzie AJ, Heintz NH, Howe AK. AMPK activity regulates trafficking of mitochondria to the leading edge during cell migration and matrix invasion. Mol Biol Cell. 2016;27:2662\u201374. https:\/\/doi.org\/10.1091\/mbc.E16-05-0286.","journal-title":"Mol Biol Cell"},{"key":"6840_CR102","doi-asserted-by":"publisher","DOI":"10.3390\/ijms241914867","author":"JP Grieco","year":"2023","unstructured":"Grieco JP, Compton SLE, Davis GN, Guinan J, Schmelz EM. Genetic and functional modifications associated with ovarian cancer cell aggregation and limited culture conditions. Int J Mol Sci. 2023. https:\/\/doi.org\/10.3390\/ijms241914867.","journal-title":"Int J Mol Sci"},{"key":"6840_CR103","doi-asserted-by":"publisher","first-page":"57","DOI":"10.1016\/s0092-8674(00)81683-9","volume":"100","author":"D Hanahan","year":"2000","unstructured":"Hanahan D, Weinberg RA. The hallmarks of cancer. Cell. 2000;100:57\u201370. https:\/\/doi.org\/10.1016\/s0092-8674(00)81683-9.","journal-title":"Cell"},{"key":"6840_CR104","doi-asserted-by":"publisher","first-page":"41","DOI":"10.1016\/S1097-2765(05)00012-2","volume":"6","author":"SR Datta","year":"2000","unstructured":"Datta SR, Katsov A, Hu L, Petros A, Fesik SW, Yaffe MB, Greenberg ME. 14\u20133\u20133 proteins and survival kinases cooperate to inactivate BAD by BH3 domain phosphorylation. Mol Cell. 2000;6:41\u201351.","journal-title":"Mol Cell"},{"key":"6840_CR105","doi-asserted-by":"publisher","first-page":"229","DOI":"10.1177\/1758834014544121","volume":"6","author":"D Luvero","year":"2014","unstructured":"Luvero D, Milani A, Ledermann JA. Treatment options in recurrent ovarian cancer: latest evidence and clinical potential. Ther Adv Med Oncol. 2014;6:229\u201339. https:\/\/doi.org\/10.1177\/1758834014544121.","journal-title":"Ther Adv Med Oncol"},{"key":"6840_CR106","doi-asserted-by":"publisher","first-page":"25865","DOI":"10.1074\/jbc.M004199200","volume":"275","author":"Y Tan","year":"2000","unstructured":"Tan Y, Demeter MR, Ruan H, Comb MJ. BAD Ser-155 phosphorylation regulates BAD\/Bcl-XL interaction and cell survival. J Biol Chem. 2000;275:25865\u20139. https:\/\/doi.org\/10.1074\/jbc.M004199200.","journal-title":"J Biol Chem"},{"key":"6840_CR107","doi-asserted-by":"publisher","first-page":"267","DOI":"10.1097\/PAP.0b013e3181b4fffa","volume":"16","author":"R Vang","year":"2009","unstructured":"Vang R, Shih Ie M, Kurman RJ. Ovarian low-grade and high-grade serous carcinoma: pathogenesis, clinicopathologic and molecular biologic features, and diagnostic problems. Adv Anat Pathol. 2009;16:267\u201382. https:\/\/doi.org\/10.1097\/PAP.0b013e3181b4fffa.","journal-title":"Adv Anat Pathol"},{"key":"6840_CR108","doi-asserted-by":"publisher","first-page":"1151","DOI":"10.1016\/s0960-9822(00)00702-8","volume":"10","author":"K Virdee","year":"2000","unstructured":"Virdee K, Parone PA, Tolkovsky AM. Phosphorylation of the pro-apoptotic protein BAD on serine 155, a novel site, contributes to cell survival. Curr Biol. 2000;10:1151\u20134. https:\/\/doi.org\/10.1016\/s0960-9822(00)00702-8.","journal-title":"Curr Biol"},{"issue":"Suppl 1","key":"6840_CR109","doi-asserted-by":"publisher","first-page":"S53","DOI":"10.1038\/onc.2009.44","volume":"27","author":"NN Danial","year":"2008","unstructured":"Danial NN. BAD: undertaker by night, candyman by day. Oncogene. 2008;27(Suppl 1):S53-70. https:\/\/doi.org\/10.1038\/onc.2009.44.","journal-title":"Oncogene"},{"key":"6840_CR110","doi-asserted-by":"publisher","first-page":"377","DOI":"10.1016\/j.molcel.2009.01.018","volume":"33","author":"SS Roy","year":"2009","unstructured":"Roy SS, Madesh M, Davies E, Antonsson B, Danial N, Hajn\u00f3czky G. Bad targets the permeability transition pore independent of Bax or Bak to switch between Ca2+-dependent cell survival and death. Mol Cell. 2009;33:377\u201388. https:\/\/doi.org\/10.1016\/j.molcel.2009.01.018.","journal-title":"Mol Cell"},{"key":"6840_CR111","doi-asserted-by":"publisher","first-page":"511","DOI":"10.1002\/ijc.24064","volume":"124","author":"S Fulda","year":"2009","unstructured":"Fulda S. Tumor resistance to apoptosis. Int J Cancer. 2009;124:511\u20135. https:\/\/doi.org\/10.1002\/ijc.24064.","journal-title":"Int J Cancer"},{"key":"6840_CR112","doi-asserted-by":"publisher","first-page":"1255","DOI":"10.3892\/ijmm.2020.4689","volume":"46","author":"J Yuan","year":"2020","unstructured":"Yuan J, Lan H, Jiang X, Zeng D, Xiao S. Bcl-2 family: novel insight into individualized therapy for ovarian cancer (Review). Int J Mol Med. 2020;46:1255\u201365. https:\/\/doi.org\/10.3892\/ijmm.2020.4689.","journal-title":"Int J Mol Med"},{"key":"6840_CR113","doi-asserted-by":"publisher","first-page":"1603","DOI":"10.1016\/j.freeradbiomed.2010.09.006","volume":"49","author":"S Reuter","year":"2010","unstructured":"Reuter S, Gupta SC, Chaturvedi MM, Aggarwal BB. Oxidative stress, inflammation, and cancer: how are they linked? Free Radic Biol Med. 2010;49:1603\u201316. https:\/\/doi.org\/10.1016\/j.freeradbiomed.2010.09.006.","journal-title":"Free Radic Biol Med"},{"issue":"12","key":"6840_CR114","doi-asserted-by":"publisher","first-page":"376","DOI":"10.1016\/j.arr.2012.10.004","volume":"2013","author":"V Sosa","year":"2013","unstructured":"Sosa V, Molin\u00e9 T, Somoza R, Paciucci R, Kondoh H, LLeonart ME. Oxidative stress and cancer: an overview. Ageing Res Rev. 2013;2013(12):376\u201390. https:\/\/doi.org\/10.1016\/j.arr.2012.10.004.","journal-title":"Ageing Res Rev"},{"key":"6840_CR115","doi-asserted-by":"publisher","first-page":"145","DOI":"10.1007\/978-1-4614-3573-0_6","volume":"748","author":"S Dr\u00f6se","year":"2012","unstructured":"Dr\u00f6se S, Brandt U. Molecular mechanisms of superoxide production by the mitochondrial respiratory chain. Adv Exp Med Biol. 2012;748:145\u201369. https:\/\/doi.org\/10.1007\/978-1-4614-3573-0_6.","journal-title":"Adv Exp Med Biol"},{"key":"6840_CR116","doi-asserted-by":"publisher","first-page":"8388258","DOI":"10.1155\/2021\/8388258","volume":"2021","author":"DN Ding","year":"2021","unstructured":"Ding DN, Xie LZ, Shen Y, Li J, Guo Y, Fu Y, Liu FY, Han FJ. Insights into the role of oxidative stress in ovarian cancer. Oxid Med Cell Longev. 2021;2021:8388258. https:\/\/doi.org\/10.1155\/2021\/8388258.","journal-title":"Oxid Med Cell Longev"},{"key":"6840_CR117","doi-asserted-by":"publisher","first-page":"5839","DOI":"10.1073\/pnas.1804932115","volume":"115","author":"R Radi","year":"2018","unstructured":"Radi R. Oxygen radicals, nitric oxide, and peroxynitrite: redox pathways in molecular medicine. Proc Natl Acad Sci U S A. 2018;115:5839\u201348. https:\/\/doi.org\/10.1073\/pnas.1804932115.","journal-title":"Proc Natl Acad Sci U S A"},{"key":"6840_CR118","doi-asserted-by":"publisher","first-page":"4223","DOI":"10.3382\/ps\/pey405","volume":"98","author":"WG Bottje","year":"2019","unstructured":"Bottje WG. Oxidative metabolism and efficiency: the delicate balancing act of mitochondria. Poult Sci. 2019;98:4223\u201330. https:\/\/doi.org\/10.3382\/ps\/pey405.","journal-title":"Poult Sci"},{"key":"6840_CR119","doi-asserted-by":"publisher","DOI":"10.1177\/1177271918755391","author":"S Kumari","year":"2018","unstructured":"Kumari S, Badana AK, G MM, G S, Malla R. Reactive oxygen species: a key constituent in cancer survival. Biomark Insights. 2018. https:\/\/doi.org\/10.1177\/1177271918755391.","journal-title":"Biomark Insights"},{"key":"6840_CR120","doi-asserted-by":"publisher","first-page":"82","DOI":"10.1016\/j.biocel.2018.03.011","volume":"98","author":"M Paku\u0142a","year":"2018","unstructured":"Paku\u0142a M, Miku\u0142a-Pietrasik J, Stryczy\u0144ski \u0141, Uruski P, Szubert S, Moszy\u0144ski R, Szpurek D, Sajdak S, Tykarski A, Ksi\u0105\u017cek K. Mitochondria-related oxidative stress contributes to ovarian cancer-promoting activity of mesothelial cells subjected to malignant ascites. Int J Biochem Cell Biol. 2018;98:82\u20138. https:\/\/doi.org\/10.1016\/j.biocel.2018.03.011.","journal-title":"Int J Biochem Cell Biol"},{"key":"6840_CR121","doi-asserted-by":"publisher","first-page":"270","DOI":"10.1016\/j.freeradbiomed.2017.06.015","volume":"110","author":"J Miku\u0142a-Pietrasik","year":"2017","unstructured":"Miku\u0142a-Pietrasik J, Uruski P, Paku\u0142a M, Maksin K, Szubert S, Wo\u017aniak A, Naumowicz E, Szpurek D, Tykarski A, Ksi\u0105\u017cek K. Oxidative stress contributes to hepatocyte growth factor-dependent pro-senescence activity of ovarian cancer cells. Free Radic Biol Med. 2017;110:270\u20139. https:\/\/doi.org\/10.1016\/j.freeradbiomed.2017.06.015.","journal-title":"Free Radic Biol Med"},{"key":"6840_CR122","doi-asserted-by":"publisher","first-page":"7089","DOI":"10.1038\/s41388-019-0949-5","volume":"38","author":"Y Han","year":"2019","unstructured":"Han Y, Kim B, Cho U, Park IS, Kim SI, Dhanasekaran DN, Tsang BK, Song YS. Mitochondrial fission causes cisplatin resistance under hypoxic conditions via ROS in ovarian cancer cells. Oncogene. 2019;38:7089\u2013105. https:\/\/doi.org\/10.1038\/s41388-019-0949-5.","journal-title":"Oncogene"},{"key":"6840_CR123","doi-asserted-by":"publisher","DOI":"10.3390\/antiox11081544","author":"D Criscuolo","year":"2022","unstructured":"Criscuolo D, Avolio R, Parri M, Romano S, Chiarugi P, Matassa DS, Esposito F. Decreased levels of GSH are associated with platinum resistance in high-grade serous ovarian cancer. Antioxidants. 2022. https:\/\/doi.org\/10.3390\/antiox11081544.","journal-title":"Antioxidants"},{"key":"6840_CR124","doi-asserted-by":"publisher","first-page":"144","DOI":"10.1016\/j.freeradbiomed.2017.01.004","volume":"104","author":"S Galadari","year":"2017","unstructured":"Galadari S, Rahman A, Pallichankandy S, Thayyullathil F. Reactive oxygen species and cancer paradox: to promote or to suppress? Free Radic Biol Med. 2017;104:144\u201364. https:\/\/doi.org\/10.1016\/j.freeradbiomed.2017.01.004.","journal-title":"Free Radic Biol Med"},{"key":"6840_CR125","doi-asserted-by":"publisher","first-page":"2185","DOI":"10.1002\/ijc.26252","volume":"130","author":"M Vandamme","year":"2012","unstructured":"Vandamme M, Robert E, Lerondel S, Sarron V, Ries D, Dozias S, Sobilo J, Gosset D, Kieda C, Legrain B, Pouvesle JM, Pape AL. ROS implication in a new antitumor strategy based on non-thermal plasma. Int J Cancer. 2012;130:2185\u201394. https:\/\/doi.org\/10.1002\/ijc.26252.","journal-title":"Int J Cancer"},{"key":"6840_CR126","doi-asserted-by":"publisher","first-page":"3534","DOI":"10.7150\/thno.70194","volume":"12","author":"Y Xuan","year":"2022","unstructured":"Xuan Y, Wang H, Yung MM, Chen F, Chan WS, Chan YS, Tsui SK, Ngan HY, Chan KK, Chan DW. SCD1\/FADS2 fatty acid desaturases equipoise lipid metabolic activity and redox-driven ferroptosis in ascites-derived ovarian cancer cells. Theranostics. 2022;12:3534\u201352. https:\/\/doi.org\/10.7150\/thno.70194.","journal-title":"Theranostics"},{"key":"6840_CR127","doi-asserted-by":"publisher","first-page":"255","DOI":"10.1038\/nature17393","volume":"532","author":"L Jiang","year":"2016","unstructured":"Jiang L, Shestov AA, Swain P, Yang C, Parker SJ, Wang QA, Terada LS, Adams ND, McCabe MT, Pietrak B, Schmidt S, Metallo CM, Dranka BP, Schwartz B, DeBerardinis RJ. Reductive carboxylation supports redox homeostasis during anchorage-independent growth. Nature. 2016;532:255\u20138. https:\/\/doi.org\/10.1038\/nature17393.","journal-title":"Nature"},{"key":"6840_CR128","doi-asserted-by":"publisher","first-page":"102329","DOI":"10.1016\/j.redox.2022.102329","volume":"53","author":"YS Kim","year":"2022","unstructured":"Kim YS, Tang PW, Welles JE, Pan W, Javed Z, Elhaw AT, Mythreye K, Kimball SR, Hempel N. HuR-dependent SOD2 protein synthesis is an early adaptation to anchorage-independence. Redox Biol. 2022;53:102329. https:\/\/doi.org\/10.1016\/j.redox.2022.102329.","journal-title":"Redox Biol"},{"key":"6840_CR129","doi-asserted-by":"publisher","first-page":"101107","DOI":"10.1016\/j.redox.2019.101107","volume":"23","author":"M Dodson","year":"2019","unstructured":"Dodson M, Castro-Portuguez R, Zhang DD. NRF2 plays a critical role in mitigating lipid peroxidation and ferroptosis. Redox Biol. 2019;23:101107. https:\/\/doi.org\/10.1016\/j.redox.2019.101107.","journal-title":"Redox Biol"},{"key":"6840_CR130","doi-asserted-by":"publisher","first-page":"2977","DOI":"10.1016\/j.bbamcr.2016.09.012","volume":"1863","author":"M Redza-Dutordoir","year":"2016","unstructured":"Redza-Dutordoir M, Averill-Bates DA. Activation of apoptosis signalling pathways by reactive oxygen species. Biochim Biophys Acta. 2016;1863:2977\u201392. https:\/\/doi.org\/10.1016\/j.bbamcr.2016.09.012.","journal-title":"Biochim Biophys Acta"},{"key":"6840_CR131","doi-asserted-by":"publisher","first-page":"388","DOI":"10.1038\/s41392-022-01253-y","volume":"7","author":"Y Meng","year":"2022","unstructured":"Meng Y, Qiu L, Zeng X, Hu X, Zhang Y, Wan X, Mao X, Wu J, Xu Y, Xiong Q, Chen Z, Zhang B, Han J. Targeting CRL4 suppresses chemoresistant ovarian cancer growth by inducing mitophagy. Signal Transduct Target Ther. 2022;7:388. https:\/\/doi.org\/10.1038\/s41392-022-01253-y.","journal-title":"Signal Transduct Target Ther"},{"key":"6840_CR132","doi-asserted-by":"publisher","first-page":"433","DOI":"10.1038\/sj.emboj.7601963","volume":"27","author":"G Twig","year":"2008","unstructured":"Twig G, Elorza A, Molina AJ, Mohamed H, Wikstrom JD, Walzer G, Stiles L, Haigh SE, Katz S, Las G, Alroy J, Wu M, Py BF, Yuan J, Deeney JT, Corkey BE, Shirihai OS. Fission and selective fusion govern mitochondrial segregation and elimination by autophagy. Embo j. 2008;27:433\u201346. https:\/\/doi.org\/10.1038\/sj.emboj.7601963.","journal-title":"Embo j"},{"key":"6840_CR133","doi-asserted-by":"publisher","first-page":"398","DOI":"10.1038\/s41419-022-04741-9","volume":"13","author":"C Vianello","year":"2022","unstructured":"Vianello C, Cocetta V, Catanzaro D, Dorn GW 2nd, De Milito A, Rizzolio F, Canzonieri V, Cecchin E, Roncato R, Toffoli G, Quagliariello V, Di Mauro A, Losito S, Maurea N, Scaffa C, Sales G, Scorrano L, Giacomello M, Montopoli M. Cisplatin resistance can be curtailed by blunting Bnip3-mediated mitochondrial autophagy. Cell Death Dis. 2022;13:398. https:\/\/doi.org\/10.1038\/s41419-022-04741-9.","journal-title":"Cell Death Dis"},{"key":"6840_CR134","doi-asserted-by":"publisher","first-page":"1379","DOI":"10.1158\/1541-7786.Mcr-19-1145","volume":"18","author":"LX Zampieri","year":"2020","unstructured":"Zampieri LX, Grasso D, Bouzin C, Brusa D, Rossignol R, Sonveaux P. Mitochondria participate in chemoresistance to cisplatin in human ovarian cancer cells. Mol Cancer Res. 2020;18:1379\u201391. https:\/\/doi.org\/10.1158\/1541-7786.Mcr-19-1145.","journal-title":"Mol Cancer Res"},{"key":"6840_CR135","doi-asserted-by":"publisher","DOI":"10.1038\/cddis.2014.94","volume":"5","author":"H Maes","year":"2014","unstructured":"Maes H, Van Eygen S, Krysko DV, Vandenabeele P, Nys K, Rillaerts K, Garg AD, Verfaillie T, Agostinis P. BNIP3 supports melanoma cell migration and vasculogenic mimicry by orchestrating the actin cytoskeleton. Cell Death Dis. 2014;5: e1127. https:\/\/doi.org\/10.1038\/cddis.2014.94.","journal-title":"Cell Death Dis"},{"key":"6840_CR136","doi-asserted-by":"publisher","DOI":"10.1172\/jci.insight.141115","author":"H Xia","year":"2020","unstructured":"Xia H, Li S, Li X, Wang W, Bian Y, Wei S, Grove S, Wang W, Vatan L, Liu JR, McLean K, Rattan R, Munkarah A, Guan JL, Kryczek I, Zou W. Autophagic adaptation to oxidative stress alters peritoneal residential macrophage survival and ovarian cancer metastasis. JCI Insight. 2020. https:\/\/doi.org\/10.1172\/jci.insight.141115.","journal-title":"JCI Insight"},{"key":"6840_CR137","doi-asserted-by":"publisher","first-page":"43","DOI":"10.1186\/s12885-023-11667-8","volume":"24","author":"J Weigelt","year":"2024","unstructured":"Weigelt J, Petrosyan M, Oliveira-Ferrer L, Schmalfeldt B, Bartmann C, Dietl J, St\u00fcrken C, Schumacher U. Ovarian cancer cells regulate their mitochondrial content and high mitochondrial content is associated with a poor prognosis. BMC Cancer. 2024;24:43. https:\/\/doi.org\/10.1186\/s12885-023-11667-8.","journal-title":"BMC Cancer"},{"key":"6840_CR138","doi-asserted-by":"publisher","first-page":"1087","DOI":"10.1038\/sj.bjc.6603377","volume":"95","author":"Y Wang","year":"2006","unstructured":"Wang Y, Liu VW, Xue WC, Cheung AN, Ngan HY. Association of decreased mitochondrial DNA content with ovarian cancer progression. Br J Cancer. 2006;95:1087\u201391. https:\/\/doi.org\/10.1038\/sj.bjc.6603377.","journal-title":"Br J Cancer"},{"key":"6840_CR139","doi-asserted-by":"publisher","first-page":"1213","DOI":"10.1016\/j.tranon.2019.05.015","volume":"12","author":"X Meng","year":"2019","unstructured":"Meng X, Schwarzenbach H, Yang Y, M\u00fcller V, Li N, Tian D, Shen Y, Gong Z. Circulating mitochondrial DNA is linked to progression and prognosis of epithelial ovarian cancer. Transl Oncol. 2019;12:1213\u201320. https:\/\/doi.org\/10.1016\/j.tranon.2019.05.015.","journal-title":"Transl Oncol"},{"key":"6840_CR140","doi-asserted-by":"publisher","first-page":"85","DOI":"10.1186\/s13048-018-0459-z","volume":"11","author":"K Kalavska","year":"2018","unstructured":"Kalavska K, Minarik T, Vlkova B, Manasova D, Kubickova M, Jurik A, Mardiak J, Sufliarsky J, Celec P, Mego M. Prognostic value of various subtypes of extracellular DNA in ovarian cancer patients. J Ovarian Res. 2018;11:85. https:\/\/doi.org\/10.1186\/s13048-018-0459-z.","journal-title":"J Ovarian Res"},{"key":"6840_CR141","doi-asserted-by":"publisher","first-page":"171","DOI":"10.1002\/biof.1257","volume":"42","author":"T Guo","year":"2016","unstructured":"Guo T, Gu C, Chen X, Kang Y, Li B, Xu C. Inhibition of succinate dehydrogenase sensitizes cyclin E-driven ovarian cancer to CDK inhibition. BioFactors. 2016;42:171\u20138. https:\/\/doi.org\/10.1002\/biof.1257.","journal-title":"BioFactors"},{"issue":"Pt 2","key":"6840_CR142","doi-asserted-by":"publisher","first-page":"425","DOI":"10.1042\/bj3480425","volume":"348","author":"HC Lee","year":"2000","unstructured":"Lee HC, Yin PH, Lu CY, Chi CW, Wei YH. Increase of mitochondria and mitochondrial DNA in response to oxidative stress in human cells. Biochem J. 2000;348(Pt 2):425\u201332.","journal-title":"Biochem J"},{"key":"6840_CR143","first-page":"5998","volume":"61","author":"VW Liu","year":"2001","unstructured":"Liu VW, Shi HH, Cheung AN, Chiu PM, Leung TW, Nagley P, Wong LC, Ngan HY. High incidence of somatic mitochondrial DNA mutations in human ovarian carcinomas. Cancer Res. 2001;61:5998\u20136001.","journal-title":"Cancer Res"},{"key":"6840_CR144","first-page":"3743","volume":"35","author":"R Huang","year":"2015","unstructured":"Huang R, Wang J, Zhong Y, Liu Y, Stokke T, Trope CG, Nesland JM, Suo Z. Mitochondrial DNA deficiency in ovarian cancer cells and cancer stem cell-like properties. Anticancer Res. 2015;35:3743\u201353.","journal-title":"Anticancer Res"},{"key":"6840_CR145","doi-asserted-by":"publisher","first-page":"1388","DOI":"10.1038\/s12276-023-01011-2","volume":"55","author":"Z Xu","year":"2023","unstructured":"Xu Z, Zhou K, Wang Z, Liu Y, Wang X, Gao T, Xie F, Yuan Q, Gu X, Liu S, Xing J. Metastatic pattern of ovarian cancer delineated by tracing the evolution of mitochondrial DNA mutations. Exp Mol Med. 2023;55:1388\u201398. https:\/\/doi.org\/10.1038\/s12276-023-01011-2.","journal-title":"Exp Mol Med"},{"key":"6840_CR146","doi-asserted-by":"publisher","DOI":"10.1002\/ctm2.1523","volume":"14","author":"F Xie","year":"2024","unstructured":"Xie F, Guo W, Wang X, Zhou K, Guo S, Liu Y, Sun T, Li S, Xu Z, Yuan Q, Zhang H, Gu X, Xing J, Liu S. Mutational profiling of mitochondrial DNA reveals an epithelial ovarian cancer-specific evolutionary pattern contributing to high oxidative metabolism. Clin Transl Med. 2024;14: e1523. https:\/\/doi.org\/10.1002\/ctm2.1523.","journal-title":"Clin Transl Med"},{"key":"6840_CR147","doi-asserted-by":"publisher","first-page":"32","DOI":"10.1186\/1746-1596-3-32","volume":"3","author":"FO Aikhionbare","year":"2008","unstructured":"Aikhionbare FO, Mehrabi S, Thompson W, Yao X, Grizzle W, Partridge E. mtDNA sequence variants in subtypes of epithelial ovarian cancer stages in relation to ethnic and age difference. Diagn Pathol. 2008;3:32. https:\/\/doi.org\/10.1186\/1746-1596-3-32.","journal-title":"Diagn Pathol"},{"key":"6840_CR148","doi-asserted-by":"publisher","first-page":"11085","DOI":"10.2147\/cmar.S277724","volume":"12","author":"J Ni","year":"2020","unstructured":"Ni J, Wang Y, Cheng X, Teng F, Wang C, Han S, Chen X, Guo W. Pathogenic heteroplasmic somatic mitochondrial DNA mutation confers platinum-resistance and recurrence of high-grade serous ovarian cancer. Cancer Manag Res. 2020;12:11085\u201393. https:\/\/doi.org\/10.2147\/cmar.S277724.","journal-title":"Cancer Manag Res"},{"key":"6840_CR149","doi-asserted-by":"publisher","DOI":"10.3390\/cells8020100","author":"P Sharma","year":"2019","unstructured":"Sharma P, Sampath H. Mitochondrial DNA Integrity: role in Health and Disease. Cells. 2019. https:\/\/doi.org\/10.3390\/cells8020100.","journal-title":"Cells"},{"key":"6840_CR150","doi-asserted-by":"publisher","first-page":"101900","DOI":"10.1016\/j.molmet.2024.101900","volume":"81","author":"MR Farook","year":"2024","unstructured":"Farook MR, Croxford Z, Morgan S, Horlock AD, Holt AK, Rees A, Jenkins BJ, Tse C, Stanton E, Davies DM, Thornton CA, Jones N, Sheldon IM, Vincent EE, Cronin JG. Loss of mitochondrial pyruvate carrier 1 supports proline-dependent proliferation and collagen biosynthesis in ovarian cancer. Mol Metab. 2024;81:101900. https:\/\/doi.org\/10.1016\/j.molmet.2024.101900.","journal-title":"Mol Metab"},{"key":"6840_CR151","doi-asserted-by":"publisher","first-page":"1819","DOI":"10.1158\/1541-7786.Mcr-18-0368","volume":"16","author":"T Fukumoto","year":"2018","unstructured":"Fukumoto T, Magno E, Zhang R. SWI\/SNF complexes in ovarian cancer: mechanistic insights and therapeutic implications. Mol Cancer Res. 2018;16:1819\u201325. https:\/\/doi.org\/10.1158\/1541-7786.Mcr-18-0368.","journal-title":"Mol Cancer Res"},{"key":"6840_CR152","doi-asserted-by":"publisher","DOI":"10.3390\/ijms22094750","author":"X Zhang","year":"2021","unstructured":"Zhang X, Shetty M, Clemente V, Linder S, Bazzaro M. Targeting mitochondrial metabolism in clear cell carcinoma of the ovaries. Int J Mol Sci. 2021. https:\/\/doi.org\/10.3390\/ijms22094750.","journal-title":"Int J Mol Sci"},{"key":"6840_CR153","doi-asserted-by":"publisher","first-page":"134","DOI":"10.1158\/2767-9764.Crc-23-0275","volume":"4","author":"JL Sottnik","year":"2024","unstructured":"Sottnik JL, Shackleford MT, Robinson SK, Villagomez FR, Bahnassy S, Oesterreich S, Hu J, Madak-Erdogan Z, Riggins RB, Corr BR, Cook LS, Trevi\u00f1o LS, Bitler BG, Sikora MJ. WNT4 regulates cellular metabolism via intracellular activity at the mitochondria in breast and gynecologic cancers. Cancer Res Commun. 2024;4:134\u201351. https:\/\/doi.org\/10.1158\/2767-9764.Crc-23-0275.","journal-title":"Cancer Res Commun"},{"key":"6840_CR154","doi-asserted-by":"publisher","first-page":"221","DOI":"10.1007\/s12672-023-00750-y","volume":"14","author":"W He","year":"2023","unstructured":"He W, Chen J, Zhou Y, Deng T, Feng Y, Luo X, Zhang C, Huang H, Liu J. Mitophagy genes in ovarian cancer: a comprehensive analysis for improved immunotherapy. Discov Oncol. 2023;14:221. https:\/\/doi.org\/10.1007\/s12672-023-00750-y.","journal-title":"Discov Oncol"},{"key":"6840_CR155","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0128106","volume":"10","author":"G Chornokur","year":"2015","unstructured":"Chornokur G, Lin HY, Tyrer JP, Lawrenson K, Dennis J, Amankwah EK, Qu X, Tsai YY, Jim HS, Chen Z, Chen AY, Permuth-Wey J, Aben KK, Anton-Culver H, Antonenkova N, Bruinsma F, Bandera EV, Bean YT, Beckmann MW, Bisogna M, Bjorge L, Bogdanova N, Brinton LA, Brooks-Wilson A, Bunker CH, Butzow R, Campbell IG, Carty K, Chang-Claude J, Cook LS, Cramer DW, Cunningham JM, Cybulski C, Dansonka-Mieszkowska A, du Bois A, Despierre E, Dicks E, Doherty JA, D\u00f6rk T, D\u00fcrst M, Easton DF, Eccles DM, Edwards RP, Ekici AB, Fasching PA, Fridley BL, Gao YT, Gentry-Maharaj A, Giles GG, Glasspool R, Goodman MT, Gronwald J, Harrington P, Harter P, Hein A, Heitz F, Hildebrandt MA, Hillemanns P, Hogdall CK, Hogdall E, Hosono S, Jakubowska A, Jensen A, Ji BT, Karlan BY, Kelemen LE, Kellar M, Kiemeney LA, Krakstad C, Kjaer SK, Kupryjanczyk J, Lambrechts D, Lambrechts S, Le ND, Lee AW, Lele S, Leminen A, Lester J, Levine DA, Liang D, Lim BK, Lissowska J, Lu K, Lubinski J, Lundvall L, Massuger LF, Matsuo K, McGuire V, McLaughlin JR, McNeish I, Menon U, Milne RL, Modugno F, Moysich KB, Ness RB, Nevanlinna H, Eilber U, Odunsi K, Olson SH, Orlow I, Orsulic S, Weber RP, Paul J, Pearce CL, Pejovic T, Pelttari LM, Pike MC, Poole EM, Risch HA, Rosen B, Rossing MA, Rothstein JH, Rudolph A, Runnebaum IB, Rzepecka IK, Salvesen HB, Schernhammer E, Schwaab I, Shu XO, Shvetsov YB, Siddiqui N, Sieh W, Song H, Southey MC, Spiewankiewicz B, Sucheston L, Teo SH, Terry KL, Thompson PJ, Thomsen L, Tangen IL, Tworoger SS, van Altena AM, Vierkant RA, Vergote I, Walsh CS, Wang-Gohrke S, Wentzensen N, Whittemore AS, Wicklund KG, Wilkens LR, Wu AH, Wu X, Woo YL, Yang H, Zheng W, Ziogas A, Hasmad HN, Berchuck A, Iversen ES, Schildkraut JM, Ramus SJ, Goode EL, Monteiro AN, Gayther SA, Narod SA, Pharoah PD, Sellers TA, Phelan CM. Common genetic variation in cellular transport genes and epithelial ovarian cancer (EOC) risk. PLoS ONE. 2015;10: e0128106. https:\/\/doi.org\/10.1371\/journal.pone.0128106.","journal-title":"PLoS ONE"},{"key":"6840_CR156","doi-asserted-by":"publisher","first-page":"3775","DOI":"10.1158\/0008-5472.Can-19-3837","volume":"80","author":"D Matei","year":"2020","unstructured":"Matei D, Nephew KP. Epigenetic attire in ovarian cancer: the emperor\u2019s new clothes. Cancer Res. 2020;80:3775\u201385. https:\/\/doi.org\/10.1158\/0008-5472.Can-19-3837.","journal-title":"Cancer Res"},{"key":"6840_CR157","doi-asserted-by":"publisher","DOI":"10.3390\/antiox13060735","author":"LY Chen","year":"2024","unstructured":"Chen LY, Shen YA, Chu LH, Su PH, Wang HC, Weng YC, Lin SF, Wen KC, Liew PL, Lai HC. Active DNA demethylase, TET1, increases oxidative phosphorylation and sensitizes ovarian cancer stem cells to mitochondrial complex I inhibitor. Antioxidants. 2024. https:\/\/doi.org\/10.3390\/antiox13060735.","journal-title":"Antioxidants"},{"key":"6840_CR158","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.2315348121","volume":"121","author":"Y Nan","year":"2024","unstructured":"Nan Y, Wu X, Luo Q, Chang W, Zhao P, Zhang L, Liu Z. OTUB2 silencing promotes ovarian cancer via mitochondrial metabolic reprogramming and can be synthetically targeted by CA9 inhibition. Proc Natl Acad Sci U S A. 2024;121: e2315348121. https:\/\/doi.org\/10.1073\/pnas.2315348121.","journal-title":"Proc Natl Acad Sci U S A"},{"key":"6840_CR159","doi-asserted-by":"publisher","first-page":"3589","DOI":"10.1038\/s41388-018-0218-z","volume":"37","author":"AR \u00d6ze\u015f","year":"2018","unstructured":"\u00d6ze\u015f AR, Pulliam N, Ertosun MG, Y\u0131lmaz \u00d6, Tang J, \u00c7opuro\u011flu E, Matei D, \u00d6ze\u015f ON, Nephew KP. Protein kinase A-mediated phosphorylation regulates STAT3 activation and oncogenic EZH2 activity. Oncogene. 2018;37:3589\u2013600. https:\/\/doi.org\/10.1038\/s41388-018-0218-z.","journal-title":"Oncogene"},{"key":"6840_CR160","doi-asserted-by":"publisher","first-page":"621","DOI":"10.1038\/ng.848","volume":"43","author":"T Hung","year":"2011","unstructured":"Hung T, Wang Y, Lin MF, Koegel AK, Kotake Y, Grant GD, Horlings HM, Shah N, Umbricht C, Wang P, Wang Y, Kong B, Langer\u00f8d A, B\u00f8rresen-Dale AL, Kim SK, van de Vijver M, Sukumar S, Whitfield ML, Kellis M, Xiong Y, Wong DJ, Chang HY. Extensive and coordinated transcription of noncoding RNAs within cell-cycle promoters. Nat Genet. 2011;43:621\u20139. https:\/\/doi.org\/10.1038\/ng.848.","journal-title":"Nat Genet"},{"key":"6840_CR161","doi-asserted-by":"publisher","first-page":"1103","DOI":"10.1038\/s41419-018-1148-y","volume":"9","author":"H Wang","year":"2018","unstructured":"Wang H, Fang L, Jiang J, Kuang Y, Wang B, Shang X, Han P, Li Y, Liu M, Zhang Z, Li P. The cisplatin-induced lncRNA PANDAR dictates the chemoresistance of ovarian cancer via regulating SFRS2-mediated p53 phosphorylation. Cell Death Dis. 2018;9:1103. https:\/\/doi.org\/10.1038\/s41419-018-1148-y.","journal-title":"Cell Death Dis"},{"key":"6840_CR162","doi-asserted-by":"publisher","first-page":"799","DOI":"10.1038\/nature05874","volume":"447","author":"E Birney","year":"2007","unstructured":"Birney E, Stamatoyannopoulos JA, Dutta A, Guig\u00f3 R, Gingeras TR, Margulies EH, Weng Z, Snyder M, Dermitzakis ET, Thurman RE, Kuehn MS, Taylor CM, Neph S, Koch CM, Asthana S, Malhotra A, Adzhubei I, Greenbaum JA, Andrews RM, Flicek P, Boyle PJ, Cao H, Carter NP, Clelland GK, Davis S, Day N, Dhami P, Dillon SC, Dorschner MO, Fiegler H, Giresi PG, Goldy J, Hawrylycz M, Haydock A, Humbert R, James KD, Johnson BE, Johnson EM, Frum TT, Rosenzweig ER, Karnani N, Lee K, Lefebvre GC, Navas PA, Neri F, Parker SC, Sabo PJ, Sandstrom R, Shafer A, Vetrie D, Weaver M, Wilcox S, Yu M, Collins FS, Dekker J, Lieb JD, Tullius TD, Crawford GE, Sunyaev S, Noble WS, Dunham I, Denoeud F, Reymond A, Kapranov P, Rozowsky J, Zheng D, Castelo R, Frankish A, Harrow J, Ghosh S, Sandelin A, Hofacker IL, Baertsch R, Keefe D, Dike S, Cheng J, Hirsch HA, Sekinger EA, Lagarde J, Abril JF, Shahab A, Flamm C, Fried C, Hackerm\u00fcller J, Hertel J, Lindemeyer M, Missal K, Tanzer A, Washietl S, Korbel J, Emanuelsson O, Pedersen JS, Holroyd N, Taylor R, Swarbreck D, Matthews N, Dickson MC, Thomas DJ, Weirauch MT, Gilbert J, Drenkow J, Bell I, Zhao X, Srinivasan KG, Sung WK, Ooi HS, Chiu KP, Foissac S, Alioto T, Brent M, Pachter L, Tress ML, Valencia A, Choo SW, Choo CY, Ucla C, Manzano C, Wyss C, Cheung E, Clark TG, Brown JB, Ganesh M, Patel S, Tammana H, Chrast J, Henrichsen CN, Kai C, Kawai J, Nagalakshmi U, Wu J, Lian Z, Lian J, Newburger P, Zhang X, Bickel P, Mattick JS, Carninci P, Hayashizaki Y, Weissman S, Hubbard T, Myers RM, Rogers J, Stadler PF, Lowe TM, Wei CL, Ruan Y, Struhl K, Gerstein M, Antonarakis SE, Fu Y, Green ED, Kara\u00f6z U, Siepel A, Taylor J, Liefer LA, Wetterstrand KA, Good PJ, Feingold EA, Guyer MS, Cooper GM, Asimenos G, Dewey CN, Hou M, Nikolaev S, Montoya-Burgos JI, L\u00f6ytynoja A, Whelan S, Pardi F, Massingham T, Huang H, Zhang NR, Holmes I, Mullikin JC, Ureta-Vidal A, Paten B, Seringhaus M, Church D, Rosenbloom K, Kent WJ, Stone EA, Batzoglou S, Goldman N, Hardison RC, Haussler D, Miller W, Sidow A, Trinklein ND, Zhang ZD, Barrera L, Stuart R, King DC, Ameur A, Enroth S, Bieda MC, Kim J, Bhinge AA, Jiang N, Liu J, Yao F, Vega VB, Lee CW, Ng P, Shahab A, Yang A, Moqtaderi Z, Zhu Z, Xu X, Squazzo S, Oberley MJ, Inman D, Singer MA, Richmond TA, Munn KJ, Rada-Iglesias A, Wallerman O, Komorowski J, Fowler JC, Couttet P, Bruce AW, Dovey OM, Ellis PD, Langford CF, Nix DA, Euskirchen G, Hartman S, Urban AE, Kraus P, Van Calcar S, Heintzman N, Kim TH, Wang K, Qu C, Hon G, Luna R, Glass CK, Rosenfeld MG, Aldred SF, Cooper SJ, Halees A, Lin JM, Shulha HP, Zhang X, Xu M, Haidar JN, Yu Y, Ruan Y, Iyer VR, Green RD, Wadelius C, Farnham PJ, Ren B, Harte RA, Hinrichs AS, Trumbower H, Clawson H, Hillman-Jackson J, Zweig AS, Smith K, Thakkapallayil A, Barber G, Kuhn RM, Karolchik D, Armengol L, Bird CP, de Bakker PI, Kern AD, Lopez-Bigas N, Martin JD, Stranger BE, Woodroffe A, Davydov E, Dimas A, Eyras E, Hallgr\u00edmsd\u00f3ttir IB, Huppert J, Zody MC, Abecasis GR, Estivill X, Bouffard GG, Guan X, Hansen NF, Idol JR, Maduro VV, Maskeri B, McDowell JC, Park M, Thomas PJ, Young AC, Blakesley RW, Muzny DM, Sodergren E, Wheeler DA, Worley KC, Jiang H, Weinstock GM, Gibbs RA, Graves T, Fulton R, Mardis ER, Wilson RK, Clamp M, Cuff J, Gnerre S, Jaffe DB, Chang JL, Lindblad-Toh K, Lander ES, Koriabine M, Nefedov M, Osoegawa K, Yoshinaga Y, Zhu B, de Jong PJ. Identification and analysis of functional elements in 1% of the human genome by the ENCODE pilot project. Nature. 2007;447:799\u2013816. https:\/\/doi.org\/10.1038\/nature05874.","journal-title":"Nature"},{"key":"6840_CR163","doi-asserted-by":"publisher","first-page":"175883592211180","DOI":"10.1177\/17588359221118010","volume":"14","author":"M Chen","year":"2022","unstructured":"Chen M, Lei N, Tian W, Li Y, Chang L. Recent advances of non-coding RNAs in ovarian cancer prognosis and therapeutics. Ther Adv Med Oncol. 2022;14:17588359221118010. https:\/\/doi.org\/10.1177\/17588359221118010.","journal-title":"Ther Adv Med Oncol"},{"key":"6840_CR164","doi-asserted-by":"publisher","first-page":"1202","DOI":"10.1016\/j.jaci.2017.08.034","volume":"141","author":"TX Lu","year":"2018","unstructured":"Lu TX, Rothenberg ME. MicroRNA. J Allergy Clin Immunol. 2018;141:1202\u20137. https:\/\/doi.org\/10.1016\/j.jaci.2017.08.034.","journal-title":"J Allergy Clin Immunol"},{"key":"6840_CR165","doi-asserted-by":"publisher","first-page":"1284853","DOI":"10.3389\/fimmu.2023.1284853","volume":"14","author":"C Li","year":"2023","unstructured":"Li C, Liu FY, Shen Y, Tian Y, Han FJ. Research progress on the mechanism of glycolysis in ovarian cancer. Front Immunol. 2023;14:1284853. https:\/\/doi.org\/10.3389\/fimmu.2023.1284853.","journal-title":"Front Immunol"},{"key":"6840_CR166","doi-asserted-by":"publisher","first-page":"1332528","DOI":"10.3389\/fonc.2024.1332528","volume":"14","author":"Z Hu","year":"2024","unstructured":"Hu Z, Yuan L, Yang X, Yi C, Lu J. The roles of long non-coding RNAs in ovarian cancer: from functions to therapeutic implications. Front Oncol. 2024;14:1332528. https:\/\/doi.org\/10.3389\/fonc.2024.1332528.","journal-title":"Front Oncol"},{"key":"6840_CR167","doi-asserted-by":"publisher","first-page":"47","DOI":"10.1038\/nrg.2015.10","volume":"17","author":"JJ Quinn","year":"2016","unstructured":"Quinn JJ, Chang HY. Unique features of long non-coding RNA biogenesis and function. Nat Rev Genet. 2016;17:47\u201362. https:\/\/doi.org\/10.1038\/nrg.2015.10.","journal-title":"Nat Rev Genet"},{"key":"6840_CR168","doi-asserted-by":"publisher","first-page":"1280","DOI":"10.1016\/j.ncrna.2024.05.005","volume":"9","author":"M Malek Mohammadi","year":"2024","unstructured":"Malek Mohammadi M, Rismanchi H, Esmailzadeh S, Farahani A, Hedayati N, Alimohammadi M, Mafi A, Farahani N, Hushmandi K. The emerging role of circular RNAs in cisplatin resistance in ovarian cancer: From molecular mechanism to future potential. Noncoding RNA Res. 2024;9:1280\u201391. https:\/\/doi.org\/10.1016\/j.ncrna.2024.05.005.","journal-title":"Noncoding RNA Res"},{"key":"6840_CR169","doi-asserted-by":"publisher","DOI":"10.3892\/ijmm.2024.5411","author":"X Wang","year":"2024","unstructured":"Wang X, Yang M, Zhu J, Zhou Y, Li G. Role of exosomal non-coding RNAs in ovarian cancer (Review). Int J Mol Med. 2024. https:\/\/doi.org\/10.3892\/ijmm.2024.5411.","journal-title":"Int J Mol Med"},{"key":"6840_CR170","doi-asserted-by":"publisher","first-page":"8","DOI":"10.1186\/s13048-020-00762-0","volume":"14","author":"S Zhao","year":"2021","unstructured":"Zhao S, Zhang Y, Pei M, Wu L, Li J. miR-145 inhibits mitochondrial function of ovarian cancer by targeting ARL5B. J Ovarian Res. 2021;14:8. https:\/\/doi.org\/10.1186\/s13048-020-00762-0.","journal-title":"J Ovarian Res"},{"key":"6840_CR171","doi-asserted-by":"publisher","first-page":"275","DOI":"10.1007\/s11033-023-09168-9","volume":"51","author":"AS Ward","year":"2024","unstructured":"Ward AS, Hall CN, Tree MO, Kohtz DS. Spheroid architecture strongly enhances miR-221\/222 expression and promotes oxidative phosphorylation in an ovarian cancer cell line through a mechanism that includes restriction of miR-9 expression. Mol Biol Rep. 2024;51:275. https:\/\/doi.org\/10.1007\/s11033-023-09168-9.","journal-title":"Mol Biol Rep"},{"key":"6840_CR172","doi-asserted-by":"publisher","first-page":"3294","DOI":"10.1158\/0008-5472.Can-19-0490","volume":"79","author":"BR Muys","year":"2019","unstructured":"Muys BR, Sousa JF, Pla\u00e7a JR, de Ara\u00fajo LF, Sarshad AA, Anastasakis DG, Wang X, Li XL, de Molfetta GA, Ram\u00e3o A, Lal A, Vidal DO, Hafner M, Silva WA. miR-450a acts as a tumor suppressor in ovarian cancer by regulating energy metabolism. Cancer Res. 2019;79:3294\u2013305. https:\/\/doi.org\/10.1158\/0008-5472.Can-19-0490.","journal-title":"Cancer Res"},{"key":"6840_CR173","doi-asserted-by":"publisher","first-page":"539","DOI":"10.1007\/s00018-018-2958-x","volume":"76","author":"M Kleemann","year":"2019","unstructured":"Kleemann M, Schneider H, Unger K, Bereuther J, Fischer S, Sander P, Marion Schneider E, Fischer-Posovszky P, Riedel CU, Handrick R, Otte K. Induction of apoptosis in ovarian cancer cells by miR-493-3p directly targeting AKT2, STK38L, HMGA2, ETS1 and E2F5. Cell Mol Life Sci. 2019;76:539\u201359. https:\/\/doi.org\/10.1007\/s00018-018-2958-x.","journal-title":"Cell Mol Life Sci"},{"key":"6840_CR174","doi-asserted-by":"publisher","first-page":"217192","DOI":"10.1016\/j.canlet.2024.217192","volume":"602","author":"H Wu","year":"2024","unstructured":"Wu H, Sun C, Cao W, Teng Q, Ma X, Schi\u00f6th HB, Dong R, Zhang Q, Kong B. Blockade of the lncRNA-PART1-PHB2 axis confers resistance to PARP inhibitor and promotes cellular senescence in ovarian cancer. Cancer Lett. 2024;602:217192. https:\/\/doi.org\/10.1016\/j.canlet.2024.217192.","journal-title":"Cancer Lett"},{"key":"6840_CR175","doi-asserted-by":"publisher","first-page":"3212","DOI":"10.3892\/or.2015.4318","volume":"34","author":"J Gao","year":"2015","unstructured":"Gao J, Liu M, Zou Y, Mao M, Shen T, Zhang C, Song S, Sun M, Zhang S, Wang B, Zhu D, Li P. Long non-coding RNA growth arrest-specific transcript 5 is involved in ovarian cancer cell apoptosis through the mitochondria-mediated apoptosis pathway. Oncol Rep. 2015;34:3212\u201321. https:\/\/doi.org\/10.3892\/or.2015.4318.","journal-title":"Oncol Rep"},{"key":"6840_CR176","doi-asserted-by":"publisher","first-page":"343","DOI":"10.1016\/j.ygyno.2018.06.013","volume":"150","author":"N Li","year":"2018","unstructured":"Li N, Zhan X, Zhan X. The lncRNA SNHG3 regulates energy metabolism of ovarian cancer by an analysis of mitochondrial proteomes. Gynecol Oncol. 2018;150:343\u201354. https:\/\/doi.org\/10.1016\/j.ygyno.2018.06.013.","journal-title":"Gynecol Oncol"},{"key":"6840_CR177","doi-asserted-by":"publisher","first-page":"69","DOI":"10.1186\/s13062-024-00520-y","volume":"19","author":"Y Sun","year":"2024","unstructured":"Sun Y, Chen X, Shi Y, Teng F, Dai C, Ge L, Xu J, Jia X. hsa_circ_0020093 suppresses ovarian cancer progression by modulating LRPPRC activity and miR-107\/LATS2 signaling. Biol Direct. 2024;19:69. https:\/\/doi.org\/10.1186\/s13062-024-00520-y.","journal-title":"Biol Direct"},{"key":"6840_CR178","doi-asserted-by":"publisher","DOI":"10.1096\/fj.202302475RRR","volume":"38","author":"Q Mu","year":"2024","unstructured":"Mu Q, Wang X, Huang K, Xia B, Bi S, Kong Y. THUMPD3-AS1 inhibits ovarian cancer cell apoptosis through the miR-320d\/ARF1 axis. Faseb J. 2024;38: e23772. https:\/\/doi.org\/10.1096\/fj.202302475RRR.","journal-title":"Faseb J"},{"key":"6840_CR179","first-page":"2128","volume":"53","author":"BJ Milner","year":"1993","unstructured":"Milner BJ, Allan LA, Eccles DM, Kitchener HC, Leonard RC, Kelly KF, Parkin DE, Haites NE. p53 mutation is a common genetic event in ovarian carcinoma. Cancer Res. 1993;53:2128\u201332.","journal-title":"Cancer Res"},{"key":"6840_CR180","doi-asserted-by":"publisher","first-page":"359","DOI":"10.1038\/nrc3711","volume":"14","author":"KT Bieging","year":"2014","unstructured":"Bieging KT, Mello SS, Attardi LD. Unravelling mechanisms of p53-mediated tumour suppression. Nat Rev Cancer. 2014;14:359\u201370. https:\/\/doi.org\/10.1038\/nrc3711.","journal-title":"Nat Rev Cancer"},{"key":"6840_CR181","doi-asserted-by":"publisher","first-page":"691","DOI":"10.1038\/nrc2715","volume":"9","author":"KH Vousden","year":"2009","unstructured":"Vousden KH, Ryan KM. p53 and metabolism. Nat Rev Cancer. 2009;9:691\u2013700. https:\/\/doi.org\/10.1038\/nrc2715.","journal-title":"Nat Rev Cancer"},{"key":"6840_CR182","doi-asserted-by":"publisher","DOI":"10.1101\/cshperspect.a026146","author":"TJ Humpton","year":"2016","unstructured":"Humpton TJ, Vousden KH. Regulation of cellular metabolism and hypoxia by p53. Cold Spring Harb Perspect Med. 2016. https:\/\/doi.org\/10.1101\/cshperspect.a026146.","journal-title":"Cold Spring Harb Perspect Med"},{"key":"6840_CR183","doi-asserted-by":"publisher","first-page":"152","DOI":"10.3389\/fendo.2019.00152","volume":"10","author":"Y Li","year":"2019","unstructured":"Li Y, Zhang MC, Xu XK, Zhao Y, Mahanand C, Zhu T, Deng H, Nevo E, Du JZ, Chen XQ. Functional diversity of p53 in human and wild animals. Front Endocrinol. 2019;10:152. https:\/\/doi.org\/10.3389\/fendo.2019.00152.","journal-title":"Front Endocrinol"},{"key":"6840_CR184","doi-asserted-by":"publisher","DOI":"10.3390\/ijms23063290","author":"Q Kong","year":"2022","unstructured":"Kong Q, Yan X, Cheng M, Jiang X, Xu L, Shen L, Yu H, Sun L. p62 promotes the mitochondrial localization of p53 through Its UBA domain and participates in regulating the sensitivity of ovarian cancer cells to cisplatin. Int J Mol Sci. 2022. https:\/\/doi.org\/10.3390\/ijms23063290.","journal-title":"Int J Mol Sci"},{"key":"6840_CR185","doi-asserted-by":"publisher","DOI":"10.3390\/cancers13143399","author":"CY Han","year":"2021","unstructured":"Han CY, Patten DA, Kim SI, Lim JJ, Chan DW, Siu MKY, Han Y, Carmona E, Parks RJ, Lee C, Di LJ, Lu Z, Chan KKL, Ku JL, Macdonald EA, Vanderhyden BC, Mes-Masson AM, Ngan HYS, Cheung ANY, Song YS, Bast RC Jr, Harper ME, Tsang BK. Nuclear HKII-P-p53 (Ser15) interaction is a prognostic biomarker for chemoresponsiveness and glycolytic regulation in epithelial ovarian cancer. Cancers. 2021. https:\/\/doi.org\/10.3390\/cancers13143399.","journal-title":"Cancers"},{"key":"6840_CR186","doi-asserted-by":"publisher","first-page":"143","DOI":"10.1186\/s12943-020-01248-9","volume":"19","author":"M Kang","year":"2020","unstructured":"Kang M, Tang B, Li J, Zhou Z, Liu K, Wang R, Jiang Z, Bi F, Patrick D, Kim D, Mitra AK, Yang-Hartwich Y. Identification of miPEP133 as a novel tumor-suppressor microprotein encoded by miR-34a pri-miRNA. Mol Cancer. 2020;19:143. https:\/\/doi.org\/10.1186\/s12943-020-01248-9.","journal-title":"Mol Cancer"},{"key":"6840_CR187","doi-asserted-by":"publisher","first-page":"1262","DOI":"10.2119\/molmed.2011.00176","volume":"17","author":"Z Yuan","year":"2011","unstructured":"Yuan Z, Cao K, Lin C, Li L, Liu HY, Zhao XY, Liu L, Deng HX, Li J, Nie CL, Wei YQ. The p53 upregulated modulator of apoptosis (PUMA) chemosensitizes intrinsically resistant ovarian cancer cells to cisplatin by lowering the threshold set by Bcl-x(L) and Mcl-1. Mol Med. 2011;17:1262\u201374. https:\/\/doi.org\/10.2119\/molmed.2011.00176.","journal-title":"Mol Med"},{"key":"6840_CR188","doi-asserted-by":"publisher","DOI":"10.3390\/cancers16081500","author":"D Kunachowicz","year":"2024","unstructured":"Kunachowicz D, Kr\u00f3l-Kulikowska M, Raczycka W, Sleziak J, B\u0142a\u017cejewska M, Kulbacka J. Heat shock proteins, a double-edged sword: significance in cancer progression, chemotherapy resistance and novel therapeutic perspectives. Cancers. 2024. https:\/\/doi.org\/10.3390\/cancers16081500.","journal-title":"Cancers"},{"key":"6840_CR189","doi-asserted-by":"publisher","first-page":"356","DOI":"10.3724\/abbs.2023246","volume":"56","author":"X Kou","year":"2024","unstructured":"Kou X, Yang X, Zhao Z, Li L. HSPA8-mediated stability of the CLPP protein regulates mitochondrial autophagy in cisplatin-resistant ovarian cancer cells. Acta Biochim Biophys Sin. 2024;56:356\u201365. https:\/\/doi.org\/10.3724\/abbs.2023246.","journal-title":"Acta Biochim Biophys Sin"},{"key":"6840_CR190","doi-asserted-by":"publisher","first-page":"137","DOI":"10.1016\/j.canlet.2012.01.030","volume":"321","author":"X Yang","year":"2012","unstructured":"Yang X, Wang J, Zhou Y, Wang Y, Wang S, Zhang W. Hsp70 promotes chemoresistance by blocking Bax mitochondrial translocation in ovarian cancer cells. Cancer Lett. 2012;321:137\u201343. https:\/\/doi.org\/10.1016\/j.canlet.2012.01.030.","journal-title":"Cancer Lett"},{"key":"6840_CR191","doi-asserted-by":"publisher","first-page":"213","DOI":"10.1042\/ebc20160009","volume":"60","author":"W Voos","year":"2016","unstructured":"Voos W, Jaworek W, Wilkening A, Bruderek M. Protein quality control at the mitochondrion. Essays Biochem. 2016;60:213\u201325. https:\/\/doi.org\/10.1042\/ebc20160009.","journal-title":"Essays Biochem"},{"key":"6840_CR192","doi-asserted-by":"publisher","first-page":"595","DOI":"10.1007\/s12038-007-0059-3","volume":"32","author":"R Arya","year":"2007","unstructured":"Arya R, Mallik M, Lakhotia SC. Heat shock genes\u2014integrating cell survival and death. J Biosci. 2007;32:595\u2013610. https:\/\/doi.org\/10.1007\/s12038-007-0059-3.","journal-title":"J Biosci"},{"key":"6840_CR193","doi-asserted-by":"publisher","first-page":"12628","DOI":"10.1038\/s41598-019-48992-7","volume":"9","author":"J Guo","year":"2019","unstructured":"Guo J, Li X, Zhang W, Chen Y, Zhu S, Chen L, Xu R, Lv Y, Wu D, Guo M, Liu X, Lu W, Deng H. HSP60-regulated mitochondrial proteostasis and protein translation promote tumor growth of ovarian cancer. Sci Rep. 2019;9:12628. https:\/\/doi.org\/10.1038\/s41598-019-48992-7.","journal-title":"Sci Rep"},{"key":"6840_CR194","doi-asserted-by":"publisher","first-page":"402","DOI":"10.1186\/s12935-022-02788-4","volume":"22","author":"DS Matassa","year":"2022","unstructured":"Matassa DS, Criscuolo D, Avolio R, Agliarulo I, Sarnataro D, Pacelli C, Scrima R, Colamatteo A, Matarese G, Capitanio N, Landriscina M, Esposito F. Regulation of mitochondrial complex III activity and assembly by TRAP1 in cancer cells. Cancer Cell Int. 2022;22:402. https:\/\/doi.org\/10.1186\/s12935-022-02788-4.","journal-title":"Cancer Cell Int"},{"key":"6840_CR195","doi-asserted-by":"publisher","first-page":"140","DOI":"10.1016\/j.pharmthera.2018.03.004","volume":"188","author":"H Dai","year":"2018","unstructured":"Dai H, Sinclair DA, Ellis JL, Steegborn C. Sirtuin activators and inhibitors: promises, achievements, and challenges. Pharmacol Ther. 2018;188:140\u201354. https:\/\/doi.org\/10.1016\/j.pharmthera.2018.03.004.","journal-title":"Pharmacol Ther"},{"key":"6840_CR196","doi-asserted-by":"publisher","first-page":"1609","DOI":"10.1038\/onc.2013.120","volume":"33","author":"M Roth","year":"2014","unstructured":"Roth M, Chen WY. Sorting out functions of sirtuins in cancer. Oncogene. 2014;33:1609\u201320. https:\/\/doi.org\/10.1038\/onc.2013.120.","journal-title":"Oncogene"},{"key":"6840_CR197","doi-asserted-by":"publisher","first-page":"1767","DOI":"10.1159\/000484063","volume":"43","author":"M Hou","year":"2017","unstructured":"Hou M, Zuo X, Li C, Zhang Y, Teng Y. Mir-29b regulates oxidative stress by targeting SIRT1 in ovarian cancer cells. Cell Physiol Biochem. 2017;43:1767\u201376. https:\/\/doi.org\/10.1159\/000484063.","journal-title":"Cell Physiol Biochem"},{"key":"6840_CR198","doi-asserted-by":"publisher","first-page":"116561","DOI":"10.1016\/j.lfs.2019.116561","volume":"232","author":"L Hou","year":"2019","unstructured":"Hou L, Wang R, Wei H, Li S, Liu L, Lu X, Yu H, Liu Z. ABT737 enhances ovarian cancer cells sensitivity to cisplatin through regulation of mitochondrial fission via Sirt3 activation. Life Sci. 2019;232:116561. https:\/\/doi.org\/10.1016\/j.lfs.2019.116561.","journal-title":"Life Sci"},{"key":"6840_CR199","doi-asserted-by":"publisher","DOI":"10.3892\/or.2021.8171","author":"L Cheng","year":"2021","unstructured":"Cheng L, Zhang D, Yan W. Ultrasound-targeted microbubble destruction-mediated overexpression of Sirtuin 3 inhibits the progression of ovarian cancer. Oncol Rep. 2021. https:\/\/doi.org\/10.3892\/or.2021.8171.","journal-title":"Oncol Rep"},{"key":"6840_CR200","doi-asserted-by":"publisher","first-page":"137","DOI":"10.1016\/j.yexcr.2018.03.030","volume":"367","author":"Y Wu","year":"2018","unstructured":"Wu Y, Gao WN, Xue YN, Zhang LC, Zhang JJ, Lu SY, Yan XY, Yu HM, Su J, Sun LK. SIRT3 aggravates metformin-induced energy stress and apoptosis in ovarian cancer cells. Exp Cell Res. 2018;367:137\u201349. https:\/\/doi.org\/10.1016\/j.yexcr.2018.03.030.","journal-title":"Exp Cell Res"},{"key":"6840_CR201","doi-asserted-by":"publisher","first-page":"754","DOI":"10.3389\/fonc.2019.00754","volume":"9","author":"X Sun","year":"2019","unstructured":"Sun X, Wang S, Gai J, Guan J, Li J, Li Y, Zhao J, Zhao C, Fu L, Li Q. SIRT5 promotes cisplatin resistance in ovarian cancer by suppressing DNA damage in a ROS-dependent manner via regulation of the Nrf2\/HO-1 pathway. Front Oncol. 2019;9:754. https:\/\/doi.org\/10.3389\/fonc.2019.00754.","journal-title":"Front Oncol"},{"key":"6840_CR202","doi-asserted-by":"publisher","first-page":"1657","DOI":"10.1002\/2211-5463.13452","volume":"12","author":"S Bandopadhyay","year":"2022","unstructured":"Bandopadhyay S, Prasad P, Ray U, Das Ghosh D, Roy SS. SIRT6 promotes mitochondrial fission and subsequent cellular invasion in ovarian cancer. FEBS Open Bio. 2022;12:1657\u201376. https:\/\/doi.org\/10.1002\/2211-5463.13452.","journal-title":"FEBS Open Bio"},{"key":"6840_CR203","doi-asserted-by":"publisher","first-page":"112369","DOI":"10.1016\/j.yexcr.2020.112369","volume":"398","author":"L Shen","year":"2021","unstructured":"Shen L, Zhou L, Xia M, Lin N, Ma J, Dong D, Sun L. PGC1\u03b1 regulates mitochondrial oxidative phosphorylation involved in cisplatin resistance in ovarian cancer cells via nucleo-mitochondrial transcriptional feedback. Exp Cell Res. 2021;398:112369. https:\/\/doi.org\/10.1016\/j.yexcr.2020.112369.","journal-title":"Exp Cell Res"},{"key":"6840_CR204","doi-asserted-by":"publisher","first-page":"89","DOI":"10.1016\/j.canlet.2019.10.029","volume":"469","author":"T Gao","year":"2020","unstructured":"Gao T, Zhang X, Zhao J, Zhou F, Wang Y, Zhao Z, Xing J, Chen B, Li J, Liu S. SIK2 promotes reprogramming of glucose metabolism through PI3K\/AKT\/HIF-1\u03b1 pathway and Drp1-mediated mitochondrial fission in ovarian cancer. Cancer Lett. 2020;469:89\u2013101. https:\/\/doi.org\/10.1016\/j.canlet.2019.10.029.","journal-title":"Cancer Lett"},{"key":"6840_CR205","doi-asserted-by":"publisher","first-page":"36","DOI":"10.1016\/j.canlet.2016.01.009","volume":"373","author":"Z Ai","year":"2016","unstructured":"Ai Z, Lu Y, Qiu S, Fan Z. Overcoming cisplatin resistance of ovarian cancer cells by targeting HIF-1-regulated cancer metabolism. Cancer Lett. 2016;373:36\u201344. https:\/\/doi.org\/10.1016\/j.canlet.2016.01.009.","journal-title":"Cancer Lett"},{"key":"6840_CR206","doi-asserted-by":"publisher","first-page":"809","DOI":"10.1038\/s41569-021-00569-6","volume":"18","author":"D Montaigne","year":"2021","unstructured":"Montaigne D, Butruille L, Staels B. PPAR control of metabolism and cardiovascular functions. Nat Rev Cardiol. 2021;18:809\u201323. https:\/\/doi.org\/10.1038\/s41569-021-00569-6.","journal-title":"Nat Rev Cardiol"},{"key":"6840_CR207","doi-asserted-by":"publisher","DOI":"10.3390\/ijms252111760","author":"SY Lee","year":"2024","unstructured":"Lee SY, Shin MJ, Choi SM, Kim DK, Choi MG, Kim JS, Suh DS, Kim JH, Kim SJ. Role of peroxisome proliferator-activated receptor \u03b1-dependent mitochondrial metabolism in ovarian cancer stem cells. Int J Mol Sci. 2024. https:\/\/doi.org\/10.3390\/ijms252111760.","journal-title":"Int J Mol Sci"},{"key":"6840_CR208","doi-asserted-by":"publisher","first-page":"618","DOI":"10.1038\/s42003-023-04993-x","volume":"6","author":"Y Zhu","year":"2023","unstructured":"Zhu Y, Wang Y, Li Y, Li Z, Kong W, Zhao X, Chen S, Yan L, Wang L, Tong Y, Shao H. Carnitine palmitoyltransferase 1A promotes mitochondrial fission by enhancing MFF succinylation in ovarian cancer. Commun Biol. 2023;6:618. https:\/\/doi.org\/10.1038\/s42003-023-04993-x.","journal-title":"Commun Biol"},{"key":"6840_CR209","doi-asserted-by":"publisher","first-page":"24","DOI":"10.3389\/fonc.2017.00024","volume":"7","author":"T Worzfeld","year":"2017","unstructured":"Worzfeld T, Pogge von Strandmann E, Huber M, Adhikary T, Wagner U, Reinartz S, M\u00fcller R. The unique molecular and cellular microenvironment of ovarian cancer. Front Oncol. 2017;7:24. https:\/\/doi.org\/10.3389\/fonc.2017.00024.","journal-title":"Front Oncol"},{"key":"6840_CR210","doi-asserted-by":"publisher","first-page":"1173","DOI":"10.1111\/cas.12987","volume":"107","author":"S Kim","year":"2016","unstructured":"Kim S, Kim B, Song YS. Ascites modulates cancer cell behavior, contributing to tumor heterogeneity in ovarian cancer. Cancer Sci. 2016;107:1173\u20138. https:\/\/doi.org\/10.1111\/cas.12987.","journal-title":"Cancer Sci"},{"key":"6840_CR211","doi-asserted-by":"publisher","first-page":"273","DOI":"10.1038\/nrc3432","volume":"13","author":"E Kipps","year":"2013","unstructured":"Kipps E, Tan DSP, Kaye SB. Meeting the challenge of ascites in ovarian cancer: new avenues for therapy and research. Nat Rev Cancer. 2013;13:273\u201382. https:\/\/doi.org\/10.1038\/nrc3432.","journal-title":"Nat Rev Cancer"},{"key":"6840_CR212","doi-asserted-by":"publisher","first-page":"114551","DOI":"10.1016\/j.celrep.2024.114551","volume":"43","author":"L Frisbie","year":"2024","unstructured":"Frisbie L, Pressimone C, Dyer E, Baruwal R, Garcia G, St Croix C, Watkins S, Calderone M, Gorecki G, Javed Z, Atiya HI, Hempel N, Pearson A, Coffman LG. Carcinoma-associated mesenchymal stem cells promote ovarian cancer heterogeneity and metastasis through mitochondrial transfer. Cell Rep. 2024;43:114551. https:\/\/doi.org\/10.1016\/j.celrep.2024.114551.","journal-title":"Cell Rep"},{"key":"6840_CR213","doi-asserted-by":"publisher","first-page":"887","DOI":"10.1038\/nrd.2018.169","volume":"17","author":"L Cassetta","year":"2018","unstructured":"Cassetta L, Pollard JW. Targeting macrophages: therapeutic approaches in cancer. Nat Rev Drug Discov. 2018;17:887\u2013904. https:\/\/doi.org\/10.1038\/nrd.2018.169.","journal-title":"Nat Rev Drug Discov"},{"key":"6840_CR214","doi-asserted-by":"publisher","first-page":"49","DOI":"10.1016\/j.cmet.2017.06.004","volume":"26","author":"G Andrejeva","year":"2017","unstructured":"Andrejeva G, Rathmell JC. Similarities and distinctions of cancer and immune metabolism in inflammation and tumors. Cell Metab. 2017;26:49\u201370. https:\/\/doi.org\/10.1016\/j.cmet.2017.06.004.","journal-title":"Cell Metab"},{"key":"6840_CR215","doi-asserted-by":"publisher","first-page":"36","DOI":"10.1016\/j.cmet.2019.06.001","volume":"30","author":"I Vitale","year":"2019","unstructured":"Vitale I, Manic G, Coussens LM, Kroemer G, Galluzzi L. Macrophages and metabolism in the tumor microenvironment. Cell Metab. 2019;30:36\u201350. https:\/\/doi.org\/10.1016\/j.cmet.2019.06.001.","journal-title":"Cell Metab"},{"key":"6840_CR216","doi-asserted-by":"publisher","first-page":"423","DOI":"10.1038\/s41586-018-0597-x","volume":"562","author":"M Song","year":"2018","unstructured":"Song M, Sandoval TA, Chae CS, Chopra S, Tan C, Rutkowski MR, Raundhal M, Chaurio RA, Payne KK, Konrad C, Bettigole SE, Shin HR, Crowley MJP, Cerliani JP, Kossenkov AV, Motorykin I, Zhang S, Manfredi G, Zamarin D, Holcomb K, Rodriguez PC, Rabinovich GA, Conejo-Garcia JR, Glimcher LH, Cubillos-Ruiz JR. IRE1\u03b1-XBP1 controls T cell function in ovarian cancer by regulating mitochondrial activity. Nature. 2018;562:423\u20138. https:\/\/doi.org\/10.1038\/s41586-018-0597-x.","journal-title":"Nature"},{"key":"6840_CR217","doi-asserted-by":"publisher","first-page":"558","DOI":"10.1007\/s10495-016-1339-x","volume":"22","author":"C Cardenas","year":"2017","unstructured":"Cardenas C, Montagna MK, Pitruzzello M, Lima E, Mor G, Alvero AB. Adipocyte microenvironment promotes Bcl(xl) expression and confers chemoresistance in ovarian cancer cells. Apoptosis. 2017;22:558\u201369. https:\/\/doi.org\/10.1007\/s10495-016-1339-x.","journal-title":"Apoptosis"},{"key":"6840_CR218","doi-asserted-by":"publisher","first-page":"1536","DOI":"10.1111\/cas.16064","volume":"115","author":"J Lee","year":"2024","unstructured":"Lee J, Han Y, Kim S, Jo H, Wang W, Cho U, Kim SI, Kim B, Song YS. Mitochondrial fission enhances IL-6-induced metastatic potential in ovarian cancer via ERK1\/2 activation. Cancer Sci. 2024;115:1536\u201350. https:\/\/doi.org\/10.1111\/cas.16064.","journal-title":"Cancer Sci"},{"key":"6840_CR219","doi-asserted-by":"publisher","first-page":"18","DOI":"10.1038\/s41389-018-0033-y","volume":"7","author":"S Manousakidi","year":"2018","unstructured":"Manousakidi S, Guillaume A, Pirou C, Bouleau S, Mignotte B, Renaud F, Le Floch N. FGF1 induces resistance to chemotherapy in ovarian granulosa tumor cells through regulation of p53 mitochondrial localization. Oncogenesis. 2018;7:18. https:\/\/doi.org\/10.1038\/s41389-018-0033-y.","journal-title":"Oncogenesis"},{"key":"6840_CR220","doi-asserted-by":"publisher","first-page":"207","DOI":"10.1038\/s41416-018-0339-8","volume":"120","author":"KL Singel","year":"2019","unstructured":"Singel KL, Grzankowski KS, Khan A, Grimm MJ, D\u2019Auria AC, Morrell K, Eng KH, Hylander B, Mayor PC, Emmons TR, L\u00e9n\u00e1rt N, Fekete R, K\u00f6rnyei Z, Muthukrishnan U, Gilthorpe JD, Urban CF, Itagaki K, Hauser CJ, Leifer C, Moysich KB, Odunsi K, D\u00e9nes \u00c1, Segal BH. Mitochondrial DNA in the tumour microenvironment activates neutrophils and is associated with worse outcomes in patients with advanced epithelial ovarian cancer. Br J Cancer. 2019;120:207\u201317. https:\/\/doi.org\/10.1038\/s41416-018-0339-8.","journal-title":"Br J Cancer"},{"key":"6840_CR221","doi-asserted-by":"publisher","first-page":"64","DOI":"10.1038\/s41419-022-04510-8","volume":"13","author":"W Tian","year":"2022","unstructured":"Tian W, Lei N, Zhou J, Chen M, Guo R, Qin B, Li Y, Chang L. Extracellular vesicles in ovarian cancer chemoresistance, metastasis, and immune evasion. Cell Death Dis. 2022;13:64. https:\/\/doi.org\/10.1038\/s41419-022-04510-8.","journal-title":"Cell Death Dis"},{"key":"6840_CR222","doi-asserted-by":"publisher","first-page":"165","DOI":"10.1186\/s12964-024-01507-y","volume":"22","author":"S Gagliardi","year":"2024","unstructured":"Gagliardi S, Mitruccio M, Di Corato R, Romano R, Aloisi A, Rinaldi R, Alifano P, Guerra F, Bucci C. Defects of mitochondria-lysosomes communication induce secretion of mitochondria-derived vesicles and drive chemoresistance in ovarian cancer cells. Cell Commun Signal. 2024;22:165. https:\/\/doi.org\/10.1186\/s12964-024-01507-y.","journal-title":"Cell Commun Signal"},{"key":"6840_CR223","doi-asserted-by":"publisher","first-page":"267","DOI":"10.1186\/s12967-024-05054-5","volume":"22","author":"X Ying","year":"2024","unstructured":"Ying X, Zheng X, Zhang X, Yin Y, Wang X. Kynurenine in IDO1(high) cancer cell-derived extracellular vesicles promotes angiogenesis by inducing endothelial mitophagy in ovarian cancer. J Transl Med. 2024;22:267. https:\/\/doi.org\/10.1186\/s12967-024-05054-5.","journal-title":"J Transl Med"},{"key":"6840_CR224","doi-asserted-by":"publisher","first-page":"33","DOI":"10.1007\/s12672-022-00492-3","volume":"13","author":"N Li","year":"2022","unstructured":"Li N, Lin G, Zhang Y, Zhang Q, Zhang H. Exosome-related protein CRABP2 is upregulated in ovarian carcinoma and enhances cell proliferation. Discov Oncol. 2022;13:33. https:\/\/doi.org\/10.1007\/s12672-022-00492-3.","journal-title":"Discov Oncol"},{"key":"6840_CR225","doi-asserted-by":"publisher","first-page":"38498","DOI":"10.1038\/srep38498","volume":"6","author":"A Reza","year":"2016","unstructured":"Reza A, Choi YJ, Yasuda H, Kim JH. Human adipose mesenchymal stem cell-derived exosomal-miRNAs are critical factors for inducing anti-proliferation signalling to A2780 and SKOV-3 ovarian cancer cells. Sci Rep. 2016;6:38498. https:\/\/doi.org\/10.1038\/srep38498.","journal-title":"Sci Rep"},{"key":"6840_CR226","doi-asserted-by":"publisher","first-page":"412","DOI":"10.1186\/1472-6882-14-412","volume":"14","author":"BX Liu","year":"2014","unstructured":"Liu BX, Zhou JY, Li Y, Zou X, Wu J, Gu JF, Yuan JR, Zhao BJ, Feng L, Jia XB, Wang RP. Hederagenin from the leaves of ivy (Hedera helix L.) induces apoptosis in human LoVo colon cells through the mitochondrial pathway. BMC Complement Altern Med. 2014;14:412. https:\/\/doi.org\/10.1186\/1472-6882-14-412.","journal-title":"BMC Complement Altern Med"},{"key":"6840_CR227","doi-asserted-by":"publisher","first-page":"1858","DOI":"10.1039\/d3md00296a","volume":"14","author":"X Huang","year":"2023","unstructured":"Huang X, Shen QK, Guo HY, Li X, Quan ZS. Pharmacological overview of hederagenin and its derivatives. RSC Med Chem. 2023;14:1858\u201384. https:\/\/doi.org\/10.1039\/d3md00296a.","journal-title":"RSC Med Chem"},{"key":"6840_CR228","doi-asserted-by":"publisher","first-page":"176188","DOI":"10.1016\/j.ejphar.2023.176188","volume":"963","author":"F Su","year":"2024","unstructured":"Su F, Sui X, Xu J, Liu Q, Li J, Liu W, Xu Y, Zhang Z, Tao F. Hederagenin suppresses ovarian cancer via targeting mitochondrial fission through dynamin-related protein 1. Eur J Pharmacol. 2024;963:176188. https:\/\/doi.org\/10.1016\/j.ejphar.2023.176188.","journal-title":"Eur J Pharmacol"},{"key":"6840_CR229","doi-asserted-by":"publisher","first-page":"104633","DOI":"10.1016\/j.fitote.2020.104633","volume":"145","author":"Y-H Wu","year":"2020","unstructured":"Wu Y-H, Wu Y-R, Li B, Yan Z-Y. Cryptotanshinone: a review of its pharmacology activities and molecular mechanisms. Fitoterapia. 2020;145:104633. https:\/\/doi.org\/10.1016\/j.fitote.2020.104633.","journal-title":"Fitoterapia"},{"key":"6840_CR230","doi-asserted-by":"publisher","first-page":"115956","DOI":"10.1016\/j.biopha.2023.115956","volume":"170","author":"T Wang","year":"2024","unstructured":"Wang T, Zhang M, Khan M, Li J, Wu X, Ma T, Li Y. Cryptotanshinone suppresses ovarian cancer via simultaneous inhibition of glycolysis and oxidative phosphorylation. Biomed Pharmacother. 2024;170:115956. https:\/\/doi.org\/10.1016\/j.biopha.2023.115956.","journal-title":"Biomed Pharmacother"},{"key":"6840_CR231","doi-asserted-by":"publisher","first-page":"33","DOI":"10.1016\/j.jep.2017.04.026","volume":"205","author":"G Jiang","year":"2017","unstructured":"Jiang G, Liu J, Ren B, Zhang L, Owusu L, Liu L, Zhang J, Tang Y, Li W. Anti-tumor and chemosensitization effects of Cryptotanshinone extracted from Salvia miltiorrhiza Bge. On ovarian cancer cells in vitro. J Ethnopharmacol. 2017;205:33\u201340. https:\/\/doi.org\/10.1016\/j.jep.2017.04.026.","journal-title":"J Ethnopharmacol"},{"key":"6840_CR232","doi-asserted-by":"publisher","first-page":"4610","DOI":"10.1002\/cam4.1691","volume":"7","author":"Y Yang","year":"2018","unstructured":"Yang Y, Cao Y, Chen L, Liu F, Qi Z, Cheng X, Wang Z. Cryptotanshinone suppresses cell proliferation and glucose metabolism via STAT3\/SIRT3 signaling pathway in ovarian cancer cells. Cancer Med. 2018;7:4610\u20138. https:\/\/doi.org\/10.1002\/cam4.1691.","journal-title":"Cancer Med"},{"key":"6840_CR233","doi-asserted-by":"publisher","DOI":"10.3390\/jof8020127","author":"AM Omar","year":"2022","unstructured":"Omar AM, Mohamed GA, Ibrahim SRM. Chaetomugilins and chaetoviridins-promising natural metabolites: structures, separation, characterization, biosynthesis, bioactivities, molecular docking, and molecular dynamics. J Fungi. 2022. https:\/\/doi.org\/10.3390\/jof8020127.","journal-title":"J Fungi"},{"key":"6840_CR234","doi-asserted-by":"publisher","first-page":"615","DOI":"10.1038\/ja.2008.81","volume":"61","author":"M Yasuhide","year":"2008","unstructured":"Yasuhide M, Yamada T, Numata A, Tanaka R. Chaetomugilins, new selectively cytotoxic metabolites, produced by a marine fish-derived Chaetomium species. J Antibiot. 2008;61:615\u201322. https:\/\/doi.org\/10.1038\/ja.2008.81.","journal-title":"J Antibiot"},{"key":"6840_CR235","doi-asserted-by":"publisher","first-page":"9967","DOI":"10.2147\/ott.S273435","volume":"13","author":"X Hu","year":"2020","unstructured":"Hu X, Wang J, Chai J, Yu X, Zhang Y, Feng Y, Qin J, Yu H. Chaetomugilin J enhances apoptosis in human ovarian cancer A2780 cells induced by cisplatin through inhibiting Pink1\/parkin mediated mitophagy. Onco Targets Ther. 2020;13:9967\u201376. https:\/\/doi.org\/10.2147\/ott.S273435.","journal-title":"Onco Targets Ther"},{"key":"6840_CR236","doi-asserted-by":"publisher","first-page":"266","DOI":"10.1002\/ptr.7309","volume":"36","author":"A Di Petrillo","year":"2022","unstructured":"Di Petrillo A, Orr\u00f9 G, Fais A, Fantini MC. Quercetin and its derivates as antiviral potentials: a comprehensive review. Phytother Res. 2022;36:266\u201378. https:\/\/doi.org\/10.1002\/ptr.7309.","journal-title":"Phytother Res"},{"key":"6840_CR237","doi-asserted-by":"publisher","first-page":"91","DOI":"10.1016\/j.cbi.2019.01.008","volume":"300","author":"D Teekaraman","year":"2019","unstructured":"Teekaraman D, Elayapillai SP, Viswanathan MP, Jagadeesan A. Quercetin inhibits human metastatic ovarian cancer cell growth and modulates components of the intrinsic apoptotic pathway in PA-1 cell line. Chem Biol Interact. 2019;300:91\u2013100. https:\/\/doi.org\/10.1016\/j.cbi.2019.01.008.","journal-title":"Chem Biol Interact"},{"key":"6840_CR238","doi-asserted-by":"publisher","first-page":"2202","DOI":"10.1002\/ptr.6171","volume":"32","author":"L Abenavoli","year":"2018","unstructured":"Abenavoli L, Izzo AA, Mili\u0107 N, Cicala C, Santini A, Capasso R. Milk thistle (Silybum marianum): a concise overview on its chemistry, pharmacological, and nutraceutical uses in liver diseases. Phytother Res. 2018;32:2202\u201313. https:\/\/doi.org\/10.1002\/ptr.6171.","journal-title":"Phytother Res"},{"key":"6840_CR239","doi-asserted-by":"publisher","first-page":"3032","DOI":"10.1111\/cas.15470","volume":"113","author":"Z Wei","year":"2022","unstructured":"Wei Z, Ye S, Feng H, Zeng C, Dong X, Zeng X, Zeng L, Lin X, Liu Q, Yao J. Silybin suppresses ovarian cancer cell proliferation by inhibiting isocitrate dehydrogenase 1 activity. Cancer Sci. 2022;113:3032\u201343. https:\/\/doi.org\/10.1111\/cas.15470.","journal-title":"Cancer Sci"},{"key":"6840_CR240","doi-asserted-by":"publisher","first-page":"153698","DOI":"10.1016\/j.phymed.2021.153698","volume":"91","author":"A Sheik","year":"2021","unstructured":"Sheik A, Kim K, Varaprasad GL, Lee H, Kim S, Kim E, Shin JY, Oh SY, Huh YS. The anti-cancerous activity of adaptogenic herb Astragalus membranaceus. Phytomedicine. 2021;91:153698. https:\/\/doi.org\/10.1016\/j.phymed.2021.153698.","journal-title":"Phytomedicine"},{"key":"6840_CR241","doi-asserted-by":"publisher","first-page":"367","DOI":"10.1007\/s12272-022-01393-3","volume":"45","author":"CX Li","year":"2022","unstructured":"Li CX, Liu Y, Zhang YZ, Li JC, Lai J. Astragalus polysaccharide: a review of its immunomodulatory effect. Arch Pharm Res. 2022;45:367\u201389. https:\/\/doi.org\/10.1007\/s12272-022-01393-3.","journal-title":"Arch Pharm Res"},{"key":"6840_CR242","doi-asserted-by":"publisher","first-page":"110376","DOI":"10.1016\/j.isci.2024.110376","volume":"27","author":"Q Peng","year":"2024","unstructured":"Peng Q, Yu Y, Ye L, Zhang S, Li Y, Hua X, Shen S, Hu D, Lu W. Astragalus polysaccharides sensitize ovarian cancer stem cells to PARPi by inhibiting mitophagy via PINK1\/Parkin signaling. iScience. 2024;27:110376. https:\/\/doi.org\/10.1016\/j.isci.2024.110376.","journal-title":"iScience"},{"key":"6840_CR243","doi-asserted-by":"publisher","first-page":"22","DOI":"10.1016\/j.biopha.2017.09.111","volume":"96","author":"Y Yu","year":"2017","unstructured":"Yu Y, Xu L, Qi L, Wang C, Xu N, Liu S, Li S, Tian H, Liu W, Xu Y, Li Z. ABT737 induces mitochondrial pathway apoptosis and mitophagy by regulating DRP1-dependent mitochondrial fission in human ovarian cancer cells. Biomed Pharmacother. 2017;96:22\u20139. https:\/\/doi.org\/10.1016\/j.biopha.2017.09.111.","journal-title":"Biomed Pharmacother"},{"key":"6840_CR244","doi-asserted-by":"publisher","first-page":"226","DOI":"10.1186\/s13048-024-01546-6","volume":"17","author":"MP Udumula","year":"2024","unstructured":"Udumula MP, Rashid F, Singh H, Pardee T, Luther S, Bhardwaj T, Anjaly K, Piloni S, Hijaz M, Gogoi R, Philip PA, Munkarah AR, Giri S, Rattan R. Targeting mitochondrial metabolism with CPI-613 in chemoresistant ovarian tumors. J Ovarian Res. 2024;17:226. https:\/\/doi.org\/10.1186\/s13048-024-01546-6.","journal-title":"J Ovarian Res"},{"key":"6840_CR245","doi-asserted-by":"publisher","DOI":"10.1126\/scitranslmed.aau1167","author":"L Zhang","year":"2019","unstructured":"Zhang L, Yao Y, Zhang S, Liu Y, Guo H, Ahmed M, Bell T, Zhang H, Han G, Lorence E, Badillo M, Zhou S, Sun Y, Di Francesco ME, Feng N, Haun R, Lan R, Mackintosh SG, Mao X, Song X, Zhang J, Pham LV, Lorenzi PL, Marszalek J, Heffernan T, Draetta G, Jones P, Futreal A, Nomie K, Wang L, Wang M. Metabolic reprogramming toward oxidative phosphorylation identifies a therapeutic target for mantle cell lymphoma. Sci Transl Med. 2019. https:\/\/doi.org\/10.1126\/scitranslmed.aau1167.","journal-title":"Sci Transl Med"},{"key":"6840_CR246","doi-asserted-by":"publisher","first-page":"770","DOI":"10.1016\/s1470-2045(17)30314-5","volume":"18","author":"A Alistar","year":"2017","unstructured":"Alistar A, Morris BB, Desnoyer R, Klepin HD, Hosseinzadeh K, Clark C, Cameron A, Leyendecker J, D\u2019Agostino R Jr, Topaloglu U, Boteju LW, Boteju AR, Shorr R, Zachar Z, Bingham PM, Ahmed T, Crane S, Shah R, Migliano JJ, Pardee TS, Miller L, Hawkins G, Jin G, Zhang W, Pasche B. Safety and tolerability of the first-in-class agent CPI-613 in combination with modified FOLFIRINOX in patients with metastatic pancreatic cancer: a single-centre, open-label, dose-escalation, phase 1 trial. Lancet Oncol. 2017;18:770\u20138. https:\/\/doi.org\/10.1016\/s1470-2045(17)30314-5.","journal-title":"Lancet Oncol"},{"key":"6840_CR247","doi-asserted-by":"publisher","DOI":"10.1002\/advs.202101267","volume":"9","author":"M Huang","year":"2022","unstructured":"Huang M, Xiong D, Pan J, Zhang Q, Wang Y, Myers CR, Johnson BD, Hardy M, Kalyanaraman B, You M. Prevention of tumor growth and dissemination by in situ vaccination with mitochondria-targeted atovaquone. Adv Sci. 2022;9: e2101267. https:\/\/doi.org\/10.1002\/advs.202101267.","journal-title":"Adv Sci"},{"key":"6840_CR248","doi-asserted-by":"publisher","first-page":"176","DOI":"10.1016\/j.addr.2016.05.020","volume":"107","author":"BK Lee","year":"2016","unstructured":"Lee BK, Yun Y, Park K. PLA micro- and nano-particles. Adv Drug Deliv Rev. 2016;107:176\u201391. https:\/\/doi.org\/10.1016\/j.addr.2016.05.020.","journal-title":"Adv Drug Deliv Rev"},{"key":"6840_CR249","doi-asserted-by":"publisher","first-page":"124028","DOI":"10.1016\/j.ijpharm.2024.124028","volume":"655","author":"Q Lu","year":"2024","unstructured":"Lu Q, Gao W, Chen Z, Liu Z, Wang J, Zeng L, Hu X, Zheng E, Zhang Q, Song H. Co-delivery of Paclitaxel\/Atovaquone\/Quercetin to regulate energy metabolism to reverse multidrug resistance in ovarian cancer by PLGA-PEG nanoparticles. Int J Pharm. 2024;655:124028. https:\/\/doi.org\/10.1016\/j.ijpharm.2024.124028.","journal-title":"Int J Pharm"},{"key":"6840_CR250","doi-asserted-by":"publisher","first-page":"721","DOI":"10.1016\/j.bbi.2009.02.013","volume":"23","author":"EG de Mejia","year":"2009","unstructured":"de Mejia EG, Ramirez-Mares MV, Puangpraphant S. Bioactive components of tea: cancer, inflammation and behavior. Brain Behav Immun. 2009;23:721\u201331. https:\/\/doi.org\/10.1016\/j.bbi.2009.02.013.","journal-title":"Brain Behav Immun"},{"key":"6840_CR251","doi-asserted-by":"publisher","first-page":"109909","DOI":"10.1016\/j.msec.2019.109909","volume":"104","author":"R Maity","year":"2019","unstructured":"Maity R, Chatterjee M, Banerjee A, Das A, Mishra R, Mazumder S, Chanda N. Gold nanoparticle-assisted enhancement in the anti-cancer properties of theaflavin against human ovarian cancer cells. Mater Sci Eng C Mater Biol Appl. 2019;104:109909. https:\/\/doi.org\/10.1016\/j.msec.2019.109909.","journal-title":"Mater Sci Eng C Mater Biol Appl"},{"key":"6840_CR252","doi-asserted-by":"publisher","first-page":"3386","DOI":"10.1021\/acs.molpharmaceut.9b00136","volume":"16","author":"P Lu","year":"2019","unstructured":"Lu P, Redd Bowman KE, Brown SM, Joklik-Mcleod M, Vander Mause ER, Nguyen HTN, Lim CS. p53-Bad: a novel tumor suppressor\/proapoptotic factor hybrid directed to the mitochondria for ovarian cancer gene therapy. Mol Pharm. 2019;16:3386\u201398. https:\/\/doi.org\/10.1021\/acs.molpharmaceut.9b00136.","journal-title":"Mol Pharm"},{"key":"6840_CR253","doi-asserted-by":"publisher","first-page":"57","DOI":"10.1186\/s12943-022-01518-8","volume":"21","author":"SW Wang","year":"2022","unstructured":"Wang SW, Gao C, Zheng YM, Yi L, Lu JC, Huang XY, Cai JB, Zhang PF, Cui YH, Ke AW. Current applications and future perspective of CRISPR\/Cas9 gene editing in cancer. Mol Cancer. 2022;21:57. https:\/\/doi.org\/10.1186\/s12943-022-01518-8.","journal-title":"Mol Cancer"},{"key":"6840_CR254","doi-asserted-by":"publisher","first-page":"48","DOI":"10.1016\/j.canlet.2019.01.017","volume":"447","author":"M Chen","year":"2019","unstructured":"Chen M, Mao A, Xu M, Weng Q, Mao J, Ji J. CRISPR-Cas9 for cancer therapy: opportunities and challenges. Cancer Lett. 2019;447:48\u201355. https:\/\/doi.org\/10.1016\/j.canlet.2019.01.017.","journal-title":"Cancer Lett"},{"key":"6840_CR255","doi-asserted-by":"publisher","first-page":"61","DOI":"10.1007\/s10142-024-01324-z","volume":"24","author":"Z Moradi","year":"2024","unstructured":"Moradi Z, Kazemi M, Jamshidi-Khalifelou R, Bahramnia V, Esfandmaz F, Rahnavard R, Moradgholi B, Piri-Gharaghie T. CRISPR du-HITI an attractive approach to targeting Long Noncoding RNA HCP5 as inhibitory factor for proliferation of ovarian cancer cell. Funct Integr Genomics. 2024;24:61. https:\/\/doi.org\/10.1007\/s10142-024-01324-z.","journal-title":"Funct Integr Genomics"},{"key":"6840_CR256","doi-asserted-by":"publisher","first-page":"303","DOI":"10.1111\/j.1432-1033.1996.0303n.x","volume":"237","author":"Z Oren","year":"1996","unstructured":"Oren Z, Shai Y. A class of highly potent antibacterial peptides derived from pardaxin, a pore-forming peptide isolated from Moses sole fish Pardachirus marmoratus. Eur J Biochem. 1996;237:303\u201310. https:\/\/doi.org\/10.1111\/j.1432-1033.1996.0303n.x.","journal-title":"Eur J Biochem"},{"key":"6840_CR257","doi-asserted-by":"publisher","DOI":"10.3390\/antiox10121883","author":"YP Chen","year":"2021","unstructured":"Chen YP, Shih PC, Feng CW, Wu CC, Tsui KH, Lin YH, Kuo HM, Wen ZH. Pardaxin activates excessive mitophagy and mitochondria-mediated apoptosis in human ovarian cancer by inducing reactive oxygen species. Antioxidants. 2021. https:\/\/doi.org\/10.3390\/antiox10121883.","journal-title":"Antioxidants"},{"key":"6840_CR258","doi-asserted-by":"publisher","first-page":"114587","DOI":"10.1016\/j.bcp.2021.114587","volume":"188","author":"C Kingnate","year":"2021","unstructured":"Kingnate C, Charoenkwan K, Kumfu S, Apaijai N, Jaiwongkam T, Khunamornpong S, Chattipakorn N, Chattipakorn SC. Platinum-based chemotherapy and bevacizumab instigate the destruction of human ovarian cancers via different signaling pathways. Biochem Pharmacol. 2021;188:114587. https:\/\/doi.org\/10.1016\/j.bcp.2021.114587.","journal-title":"Biochem Pharmacol"},{"key":"6840_CR259","doi-asserted-by":"publisher","first-page":"5634724","DOI":"10.1155\/2022\/5634724","volume":"2022","author":"L Shen","year":"2022","unstructured":"Shen L, Zhan X. Mitochondrial dysfunction pathway alterations offer potential biomarkers and therapeutic targets for ovarian cancer. Oxid Med Cell Longev. 2022;2022:5634724. https:\/\/doi.org\/10.1155\/2022\/5634724.","journal-title":"Oxid Med Cell Longev"},{"key":"6840_CR260","doi-asserted-by":"publisher","first-page":"6902","DOI":"10.1021\/jm800669s","volume":"51","author":"CM Park","year":"2008","unstructured":"Park CM, Bruncko M, Adickes J, Bauch J, Ding H, Kunzer A, Marsh KC, Nimmer P, Shoemaker AR, Song X, Tahir SK, Tse C, Wang X, Wendt MD, Yang X, Zhang H, Fesik SW, Rosenberg SH, Elmore SW. Discovery of an orally bioavailable small molecule inhibitor of prosurvival B-cell lymphoma 2 proteins. J Med Chem. 2008;51:6902\u201315. https:\/\/doi.org\/10.1021\/jm800669s.","journal-title":"J Med Chem"},{"key":"6840_CR261","doi-asserted-by":"publisher","DOI":"10.1038\/cddis.2014.413","volume":"5","author":"D Schmid","year":"2014","unstructured":"Schmid D, Jarvis GE, Fay F, Small DM, Greene MK, Majkut J, Spence S, McLaughlin KM, McCloskey KD, Johnston PG, Kissenpfennig A, Longley DB, Scott CJ. Nanoencapsulation of ABT-737 and camptothecin enhances their clinical potential through synergistic antitumor effects and reduction of systemic toxicity. Cell Death Dis. 2014;5: e1454. https:\/\/doi.org\/10.1038\/cddis.2014.413.","journal-title":"Cell Death Dis"},{"key":"6840_CR262","doi-asserted-by":"publisher","first-page":"1107","DOI":"10.1080\/14740338.2018.1532500","volume":"17","author":"C Bottoni","year":"2018","unstructured":"Bottoni C, Scambia G, Fagotti A, Petrillo M. The safety of bevazicumab for the treatment of ovarian cancer. Expert Opin Drug Saf. 2018;17:1107\u201313. https:\/\/doi.org\/10.1080\/14740338.2018.1532500.","journal-title":"Expert Opin Drug Saf"},{"key":"6840_CR263","doi-asserted-by":"publisher","first-page":"191","DOI":"10.1016\/j.canlet.2017.09.050","volume":"411","author":"F Pistollato","year":"2017","unstructured":"Pistollato F, Calder\u00f3n Iglesias R, Ruiz R, Aparicio S, Crespo J, Dzul Lopez L, Giampieri F, Battino M. The use of natural compounds for the targeting and chemoprevention of ovarian cancer. Cancer Lett. 2017;411:191\u2013200. https:\/\/doi.org\/10.1016\/j.canlet.2017.09.050.","journal-title":"Cancer Lett"},{"key":"6840_CR264","doi-asserted-by":"publisher","first-page":"316","DOI":"10.1038\/nrg2971","volume":"12","author":"MA Kay","year":"2011","unstructured":"Kay MA. State-of-the-art gene-based therapies: the road ahead. Nat Rev Genet. 2011;12:316\u201328. https:\/\/doi.org\/10.1038\/nrg2971.","journal-title":"Nat Rev Genet"},{"key":"6840_CR265","doi-asserted-by":"publisher","first-page":"1965","DOI":"10.2147\/ijn.S394383","volume":"18","author":"Y Wu","year":"2023","unstructured":"Wu Y, Yang Y, Lv X, Gao M, Gong X, Yao Q, Liu Y. Nanoparticle-based combination therapy for ovarian cancer. Int J Nanomedicine. 2023;18:1965\u201387. https:\/\/doi.org\/10.2147\/ijn.S394383.","journal-title":"Int J Nanomedicine"},{"key":"6840_CR266","doi-asserted-by":"publisher","first-page":"1285","DOI":"10.1124\/jpet.105.100701","volume":"317","author":"J Zhang","year":"2006","unstructured":"Zhang J, Huang M, Guan S, Bi HC, Pan Y, Duan W, Chan SY, Chen X, Hong YH, Bian JS, Yang HY, Zhou S. A mechanistic study of the intestinal absorption of cryptotanshinone, the major active constituent of Salvia miltiorrhiza. J Pharmacol Exp Ther. 2006;317:1285\u201394. https:\/\/doi.org\/10.1124\/jpet.105.100701.","journal-title":"J Pharmacol Exp Ther"},{"key":"6840_CR267","doi-asserted-by":"publisher","first-page":"33","DOI":"10.1002\/ptr.6750","volume":"35","author":"Z Rashidi","year":"2021","unstructured":"Rashidi Z, Khosravizadeh Z, Talebi A, Khodamoradi K, Ebrahimi R, Amidi F. Overview of biological effects of Quercetin on ovary. Phytother Res. 2021;35:33\u201349. https:\/\/doi.org\/10.1002\/ptr.6750.","journal-title":"Phytother Res"},{"key":"6840_CR268","doi-asserted-by":"publisher","DOI":"10.3390\/ph14121315","author":"F Rezaei-Tazangi","year":"2021","unstructured":"Rezaei-Tazangi F, Roghani-Shahraki H, Khorsand Ghaffari M, Abolhasani Zadeh F, Boostan A, ArefNezhad R, Motedayyen H. The therapeutic potential of common herbal and nano-based herbal formulations against ovarian cancer: new insight into the current evidence. Pharmaceuticals. 2021. https:\/\/doi.org\/10.3390\/ph14121315.","journal-title":"Pharmaceuticals"},{"key":"6840_CR269","doi-asserted-by":"publisher","first-page":"5","DOI":"10.1016\/j.semcancer.2019.08.014","volume":"69","author":"D Kashyap","year":"2021","unstructured":"Kashyap D, Tuli HS, Yerer MB, Sharma A, Sak K, Srivastava S, Pandey A, Garg VK, Sethi G, Bishayee A. Natural product-based nanoformulations for cancer therapy: opportunities and challenges. Semin Cancer Biol. 2021;69:5\u201323. https:\/\/doi.org\/10.1016\/j.semcancer.2019.08.014.","journal-title":"Semin Cancer Biol"},{"key":"6840_CR270","doi-asserted-by":"publisher","first-page":"631","DOI":"10.1016\/j.colsurfb.2014.12.041","volume":"126","author":"M Estanqueiro","year":"2015","unstructured":"Estanqueiro M, Amaral MH, Concei\u00e7\u00e3o J, Sousa Lobo JM. Nanotechnological carriers for cancer chemotherapy: the state of the art. Colloids Surf B Biointerfaces. 2015;126:631\u201348. https:\/\/doi.org\/10.1016\/j.colsurfb.2014.12.041.","journal-title":"Colloids Surf B Biointerfaces"},{"key":"6840_CR271","doi-asserted-by":"publisher","first-page":"252","DOI":"10.1016\/j.ejmech.2018.12.051","volume":"164","author":"DM Wu","year":"2019","unstructured":"Wu DM, Wang YJ, Fan SH, Zhang ZF, Shan Q, Lu J, Chen GQ, Zheng YL. High-throughput screening of novel pyruvate dehydrogenase kinases inhibitors and biological evaluation of their in vitro and in vivo antiproliferative activity. Eur J Med Chem. 2019;164:252\u201362. https:\/\/doi.org\/10.1016\/j.ejmech.2018.12.051.","journal-title":"Eur J Med Chem"},{"key":"6840_CR272","doi-asserted-by":"publisher","first-page":"179","DOI":"10.1007\/s00018-022-04153-0","volume":"79","author":"AV Vlasov","year":"2022","unstructured":"Vlasov AV, Osipov SD, Bondarev NA, Uversky VN, Borshchevskiy VI, Yanyushin MF, Manukhov IV, Rogachev AV, Vlasova AD, Ilyinsky NS, Kuklin AI, Dencher NA, Gordeliy VI. ATP synthase F(O)F(1) structure, function, and structure-based drug design. Cell Mol Life Sci. 2022;79:179. https:\/\/doi.org\/10.1007\/s00018-022-04153-0.","journal-title":"Cell Mol Life Sci"},{"key":"6840_CR273","doi-asserted-by":"publisher","first-page":"606","DOI":"10.1016\/j.ccell.2025.03.012","volume":"43","author":"J Luo","year":"2025","unstructured":"Luo J, Solit DB. Leveraging real-world data to advance biomarker discovery and precision oncology. Cancer Cell. 2025;43:606\u201310. https:\/\/doi.org\/10.1016\/j.ccell.2025.03.012.","journal-title":"Cancer Cell"}],"container-title":["Journal of Translational Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12967-025-06840-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12967-025-06840-5\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12967-025-06840-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,9,7]],"date-time":"2025-09-07T21:36:37Z","timestamp":1757280997000},"score":1,"resource":{"primary":{"URL":"https:\/\/translational-medicine.biomedcentral.com\/articles\/10.1186\/s12967-025-06840-5"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,7,24]]},"references-count":273,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["6840"],"URL":"https:\/\/doi.org\/10.1186\/s12967-025-06840-5","relation":{},"ISSN":["1479-5876"],"issn-type":[{"value":"1479-5876","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,7,24]]},"assertion":[{"value":"8 March 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"7 July 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"24 July 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not applicable.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"All authors approved the version of the manuscript to be published.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare that they have no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"819"}}